Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X1050.Time spend outdoors in summer,44997,0.0189956626065274,0.0167974245552663,-0.0139272895217945,0.0519186147348493,0.258116866105084
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X1060.Time spent outdoors in winter,39254,0.0199186778550159,0.0188494628207526,-0.0170262692736592,0.0568636249836909,0.290644119966397
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X1070.Time spent watching television (TV),47304,0.0775473942582949,0.0168854446031596,0.0444519228361021,0.110642865680488,4.38971267257024e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X1080.Time spent using computer,39233,-0.0358629465591,0.0173896312989086,-0.0699466239049609,-0.00177926921323918,0.0391840580599918
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X1090.Time spent driving,34011,-0.039353901567572,0.0190323975359505,-0.076657400738035,-0.00205040239710894,0.0386727580881502
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X1160.Sleep duration,49861,-0.00152708878373119,0.0152897053697247,-0.0314949113083915,0.0284407337409292,0.92044243616166
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,16690,0.00494102416261571,0.0138659259126453,-0.022236190626169,0.0321182389514005,0.721588298386758
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,16690,0.00521339816454829,0.0135467270166186,-0.0213381867880242,0.0317649831171207,0.700356726805806
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,16690,-0.00223529204302561,0.0154829332871839,-0.032581841285906,0.0281112571998548,0.885208980592233
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,16690,0.0109264982802571,0.015806863789427,-0.0200549547470199,0.0419079513075341,0.489417923198077
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,16690,0.0121054116974813,0.0161038105334947,-0.0194580569481683,0.0436688803431309,0.452235475989019
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,16690,-0.0311355337616112,0.0341097651601361,-0.097990673475478,0.0357196059522556,0.361358773400372
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,16690,0.00662321138075893,0.0355917651494372,-0.063136648312138,0.0763830710736558,0.852377773517561
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,16690,-0.0244695951871783,0.0242707412720693,-0.0720402480804342,0.0231010577060776,0.313376372222123
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,16690,-0.0028558322954887,0.0178453673170048,-0.0378327522368181,0.0321210876458407,0.87285769580781
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,16690,0.00457627990519687,0.0122214969075294,-0.0193778540335607,0.0285304138439544,0.708077938852499
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120039#18.Location of pain during the past week_Upper back,16690,0.0318713163843419,0.0177114910510795,-0.00284320607577402,0.0665858388444578,0.0719622607570364
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120039#19.Location of pain during the past week_Lower back,16690,0.0099130625459649,0.00989966245627692,-0.00949027586833787,0.0293164009602677,0.316670422151594
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,16690,-0.00848432571949302,0.0128260199319766,-0.0336233247861671,0.0166546733471811,0.508305175963522
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,16690,0.0182813964078279,0.0190081517792481,-0.0189745810794983,0.0555373738951542,0.336181044761814
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,16690,0.00152663702442457,0.0180339455391393,-0.0338198962322885,0.0368731702811376,0.9325378626897
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,16690,0.0118005314879728,0.0239797018737363,-0.0351996841845504,0.0588007471604959,0.622651586949286
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,16690,0.0293478973502032,0.0226143950528036,-0.0149763169532918,0.0736721116536983,0.1943902005771
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120039#7.Location of pain during the past week_Left hip,16690,-0.00116113797180008,0.0138764746978127,-0.028359028379513,0.0260367524359129,0.933314466541193
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120039#8.Location of pain during the past week_Right hip,16690,0.00936761993741291,0.0132095911323538,-0.0165231786820004,0.0352584185568263,0.47823950860217
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,16690,0.0077787244825638,0.0164191992338633,-0.0244029060158083,0.0399603549809359,0.635678799151855
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120040.Fatigue severity over the past week,16703,-0.00759365602016709,0.0271593117717705,-0.0608259070928373,0.0456385950525031,0.779790345904168
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120041.Waking unrefreshed severity over the past week,16703,0.0146365847756388,0.0269136236494687,-0.0381141175773198,0.0673872871285974,0.58656192236657
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120042.Cognitive symptoms severity over the past week,16702,-0.00347418694737606,0.029220819091021,-0.0607469923657772,0.0537986184710251,0.905360579987511
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120098.Mobility problems today,16711,-0.00286857586853494,0.03208843313776,-0.0657619048185445,0.0600247530814746,0.928768316788825
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120099.Self-care problems today,16711,-0.0553658927653969,0.0500970036627596,-0.153556019944406,0.0428242344136119,0.269100241846595
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120100.Problems doing usual activities,16711,0.0157726665126765,0.030446411484342,-0.0439022999966338,0.0754476330219867,0.604432471370732
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120101.Pain or discomfort today,16711,-0.00331283046458928,0.0271124257789556,-0.0564531849913423,0.0498275240621637,0.902751092843597
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120102.Anxiety or depression today,16711,0.0285626866022239,0.0329264440282766,-0.0359731436931981,0.093098516897646,0.3856972738518
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120103.Scale to indicate how health is today,16656,-0.00253796404841731,0.00429977512219128,-0.0109655232879122,0.00588959519107759,0.555027673880101
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,16671,-0.036907800647614,0.0334662802645762,-0.102501709966183,0.0286861086709555,0.270114560198861
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",16649,0.00507580247414114,0.034311704155732,-0.0621751376710935,0.0723267426193758,0.882398147379572
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",16681,0.0193716921218832,0.0270546249292287,-0.0336553727394051,0.0723987569831714,0.473988128868612
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,16682,-0.00868465627339139,0.0276368436821713,-0.0628528698904472,0.0454835573436644,0.753341199944901
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,16688,-0.00230590779169704,0.0359930198165636,-0.0728522266321616,0.0682404110487675,0.948918907266378
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120109.Feeling bad about self over the last two weeks,16644,-0.00869940850178433,0.0361289261644079,-0.0795121037840237,0.0621132867804551,0.80972247161905
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120110.Trouble concentrating over the last two weeks,16688,0.0134981638453364,0.0359003421602894,-0.0568665067888307,0.0838628344795036,0.706929234542454
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,16671,0.0151079497105044,0.0525142599373228,-0.0878199997666483,0.118035899187657,0.773585842501519
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,16601,0.0682172265640867,0.0710339097054602,-0.0710092364586153,0.207443689586789,0.336894429605989
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",11616,-0.021892611807276,0.037526208000284,-0.0954439794878327,0.0516587558732807,0.559638591196422
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X1269.Exposure to tobacco smoke at home,45096,0.0710154099447864,0.0368381008675491,-0.00118726775560976,0.143218087645183,0.0538899331799612
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,42084,0.0541258551754012,0.0226401115669267,0.00975123650422494,0.0985004738465775,0.0168203728237359
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X1289.Cooked vegetable intake,48423,-0.00890748437613441,0.0160294500720785,-0.0403252065174082,0.0225102377651394,0.578421980969526
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X1299.Salad  or  raw vegetable intake,47109,-0.0881227562843114,0.0169314854464975,-0.121308467759446,-0.0549370448091763,1.95157528145849e-07
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X1309.Fresh fruit intake,48313,-0.0492540645795742,0.0167825948685365,-0.0821479505219057,-0.0163601786372427,0.00333887444520092
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X1319.Dried fruit intake,45635,-0.0408692570770876,0.0173004205307038,-0.074778081317267,-0.00696043283690815,0.018164770737475
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X134.Number of self-reported cancers,50291,0.0445157182940601,0.0296041502869909,-0.013508416268442,0.102539852856562,0.132665280544141
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X135.Number of self-reported non-cancer illnesses,50292,0.0835821215953521,0.0160100195249619,0.0522024833264267,0.114961759864277,1.79039018235177e-07
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,"X136.Number of operations, self-reported",50292,0.0202280095203203,0.0157399070707267,-0.0106222083383041,0.0510782273789447,0.198748723309713
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X137.Number of treatments or medications taken,50292,0.0811154628452557,0.0156551774151654,0.0504313151115315,0.11179961057898,2.21095908595486e-07
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X1438.Bread intake,48817,0.00275645643220223,0.0025854569187145,-0.00231103912847818,0.00782395199288264,0.286366090046632
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X1458.Cereal intake,47753,-0.0486141338943597,0.0158730331326754,-0.0797252788344035,-0.0175029889543158,0.00219481341593882
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X1488.Tea intake,48531,-0.00277345691569433,0.00247133674080255,-0.00761727692766733,0.00207036309627867,0.261761840183666
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X1498.Coffee intake,46337,-0.00868680611189293,0.0159656813088633,-0.039979541477265,0.0226059292534791,0.586380498037056
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X1528.Water intake,46484,-0.0194749322042299,0.0162881139913973,-0.0513996356273686,0.0124497712189088,0.231838104607017
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X1568.Average weekly red wine intake,34237,-0.064458313230227,0.0185310085756267,-0.100779090038455,-0.0281375364219986,0.00050503790195383
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,34231,-0.0466891445775639,0.018963116106995,-0.0838568521472742,-0.0095214370078537,0.0138173933230442
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X1588.Average weekly beer plus cider intake,34322,-0.0302157759450186,0.021028309886597,-0.0714312633227488,0.0109997114327116,0.150752860709208
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X1598.Average weekly spirits intake,34177,-0.00952861741078826,0.0204958732061452,-0.0497005288948328,0.0306432940732563,0.642003030158245
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X1608.Average weekly fortified wine intake,34297,0.0651632974788437,0.0332134769239461,6.48827079092751e-05,0.130261712249778,0.0497759760238948
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X1737.Childhood sunburn occasions,37734,-0.0605899414111806,0.018880479255847,-0.0975956807526407,-0.0235842020697204,0.00133247879876268
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X1807.Father's age at death,37019,-0.000192876351434601,0.00285748344679715,-0.00579354390715701,0.0054077912042878,0.946185080110395
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X1845.Mother's age,19119,0.01139233543604,0.0065157729806991,-0.00137857960613024,0.0241632504782102,0.0804066539924468
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X1873.Number of full brothers,49381,0.0256819942262308,0.0153446819246192,-0.00439358234602277,0.0557575707984843,0.0942010338441006
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X1883.Number of full sisters,49388,0.0240811707025962,0.0154335160372899,-0.00616852073049194,0.0543308621356844,0.118691500465488
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X20015.Sitting height,49898,-0.0177155637384071,0.00325567584914755,-0.0240966884027363,-0.0113344390740779,5.30998686149691e-08
NFKBIE,NF-kappa-B inhibitor epsilon,Cognitive function,X20016.Fluid intelligence score,16121,-0.0102525444359192,0.0257383567196727,-0.0606997236064777,0.0401946347346394,0.690386941189643
NFKBIE,NF-kappa-B inhibitor epsilon,Cognitive function,X20018.Prospective memory result,16795,-0.0350540879466141,0.034543034172381,-0.102758434924481,0.0326502590312528,0.310218333131128
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),15910,-0.00189478455999997,0.00444186471930163,-0.0106008394098312,0.00681127028983123,0.669695323414758
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),15894,-0.000533698985077546,0.00444129045836528,-0.0092386282834735,0.00817123031331841,0.90435194447898
NFKBIE,NF-kappa-B inhibitor epsilon,Cognitive function,X20023.Mean time to correctly identify matches,49683,0.0023286294396869,0.00261500288537997,-0.00279677621565785,0.00745403509503165,0.373208068270754
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20107#1.Illnesses of father_Heart disease,43740,0.00416691288764828,0.00558602759208354,-0.00678170119283545,0.015115526968132,0.455699942019026
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,42867,-0.0097642086926139,0.0123227513333114,-0.0339168013059042,0.0143883839206764,0.42814792353001
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,42799,0.0125597721302824,0.0165162014471103,-0.0198119827060537,0.0449315269666186,0.446988868835468
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20107#12.Illnesses of father_Severe depression,42837,0.0100591243528806,0.0139654434826995,-0.0173131448732105,0.0374313935789717,0.47135237250005
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,42861,0.00490911735971914,0.00995408767371321,-0.0146008944807587,0.024419129200197,0.621890746386664
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20107#2.Illnesses of father_Stroke,43197,-0.00172787222540275,0.00719512086355172,-0.0158303091179641,0.0123745646671586,0.810218997655378
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20107#3.Illnesses of father_Lung cancer,43078,0.00287717663301875,0.00908943076858686,-0.0149381076734115,0.020692460939449,0.751593517315514
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,42883,0.00172462520220963,0.0113704461655133,-0.0205614492821964,0.0240106996866156,0.879443103308077
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,43159,-0.0022704161357311,0.00832422209148584,-0.0185858914350433,0.0140450591635811,0.785048128072103
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20107#8.Illnesses of father_High blood pressure,43301,0.0126353018953563,0.00627283747985166,0.000340540434847018,0.0249300633558655,0.0439854679782147
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20107#9.Illnesses of father_Diabetes,43035,0.0129109447781748,0.0086756606570463,-0.00409335010963595,0.0299152396659856,0.136710756692838
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20110#1.Illnesses of mother_Heart disease,45864,0.00391393044741911,0.00639863014087996,-0.00862738462870561,0.0164552455235438,0.540750837429085
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,45577,0.0110180971034105,0.00917297753727673,-0.00696093886965188,0.0289971330764729,0.22970031579957
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,45435,0.00700729417164427,0.0198196014973822,-0.0318391247632248,0.0458537131065133,0.723674991238482
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20110#12.Illnesses of mother_Severe depression,45504,0.0255557048916393,0.0102635717792871,0.00543910420423658,0.045672305579042,0.0127799135543714
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20110#2.Illnesses of mother_Stroke,45741,-0.00199345193328102,0.00726856680970677,-0.0162398428803063,0.0122529390137442,0.783888724715756
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,45531,0.000830467901278607,0.0128531330754983,-0.024361672926698,0.0260226087292552,0.948483135310829
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,45491,0.00218393579913802,0.0115285684938199,-0.020412058448749,0.024779930047025,0.849751283892326
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,45532,0.00416978202836982,0.00937317027476758,-0.0142016317101746,0.0225411957669143,0.656420463243724
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,45583,0.00919502502648017,0.0107976998758402,-0.0119684667301666,0.030358516783127,0.394455844651929
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,45935,0.0033544043084668,0.0055318869899409,-0.00748809419181738,0.014196902808751,0.544268002830586
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20110#9.Illnesses of mother_Diabetes,45646,0.00824150661704125,0.00852816463066892,-0.00847369605906984,0.0249567092931523,0.333855736046956
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,39332,0.00319717558603845,0.00894295915144814,-0.0143310243507999,0.0207253755228768,0.720713779763701
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,39048,-0.0121747919100013,0.0357153918771906,-0.0821769599892949,0.0578273761692922,0.733193034502978
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,39036,-0.0332620534458932,0.0360856086232775,-0.103989846347517,0.0374657394557308,0.356662614488632
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,39156,-0.00820604070598609,0.0105264804675108,-0.0288379424223073,0.0124258610103351,0.435653637327104
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,39070,0.013110088739578,0.0208880684432771,-0.027830525409245,0.0540507028884011,0.530246559344637
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20111#2.Illnesses of siblings_Stroke,39116,-0.0188651896088169,0.0150683987743404,-0.0483992512065241,0.0106688719888903,0.210588129793018
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,39068,0.035244857709293,0.0178877726311088,0.000184823352319792,0.0703048920662663,0.0488073420361754
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,39071,0.0175475071126508,0.0175051675971927,-0.0167626213778469,0.0518576356031486,0.316147630920564
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,39095,-0.00685750282919213,0.0131390450198752,-0.0326100310681475,0.0188950254097632,0.601730450258266
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,39115,0.00893804795921376,0.0161996230851966,-0.0228132132877716,0.0406893092061991,0.581126780694375
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,39469,0.0022515451092866,0.00667787851159592,-0.0108370967734414,0.0153401869920146,0.735994516598944
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,39253,0.00620623173724007,0.00948890925282558,-0.0123920303982981,0.0248044938727782,0.513082703633401
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X20127.Neuroticism score,39968,0.0252059747866934,0.0160590245595501,-0.00626971335002473,0.0566816629234115,0.116520035956039
NFKBIE,NF-kappa-B inhibitor epsilon,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,16121,0.0510263821629993,0.026108345883256,-0.00014597576818233,0.102198740094181,0.0506701742660501
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X20161.Pack years of smoking,15312,0.0203030016139865,0.00473683834104743,0.0110187984655335,0.0295872047624394,1.82873520462316e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,15312,0.0208637448845696,0.00467283007710546,0.0117049979334429,0.0300224918356963,8.06771529391909e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Cognitive function,X20191.Fluid intelligence score,12437,0.0385524699378281,0.0289961205833979,-0.0182799264056317,0.0953848662812879,0.183683311565437
NFKBIE,NF-kappa-B inhibitor epsilon,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,12438,0.0390148109787789,0.0294973833606957,-0.0188000604081847,0.0968296823657425,0.185975074515115
NFKBIE,NF-kappa-B inhibitor epsilon,Cognitive function,X20240.Maximum digits remembered correctly,11178,-0.00548638297524067,0.0313278458930802,-0.0668889609256778,0.0559161949751964,0.860982236143411
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X20255.Spirometry QC measure,37418,0.0487909235048484,0.020414443680215,0.00877861389162702,0.0888032331180697,0.0168523855387117
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X20261.avMSE,11018,-0.01106837255743,0.0051822506113607,-0.021225583755697,-0.000911161359163028,0.0327158116213316
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X20262.Myopia diagnosis,11018,0.0730509140566624,0.0393261602004729,-0.00402835993626435,0.150130188049589,0.0632574540761918
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X20280.Glucose-lactate,28725,0.0271132659654048,0.00331735937685904,0.0206112415867611,0.0336152903440485,3.12693053552569e-16
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X20281.Spectrometer-corrected alanine,28788,0.0450849799790931,0.00332688242772345,0.0385642904207551,0.0516056695374311,1.03947479078674e-41
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,15715,-5.23069645640021e-05,0.0175510664167985,-0.034452397141489,0.034347783212361,0.997622127786928
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,15712,0.00569939231367382,0.0343346616977275,-0.061596544613872,0.0729953292412196,0.868162790188627
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),15710,-0.00378459965057548,0.0423349666211783,-0.0867611342280849,0.0791919349269339,0.928767911601461
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),15710,-0.00335538603161647,0.0166430823536614,-0.0359758274447927,0.0292650553815598,0.840225451566842
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),15710,0.0236420137136464,0.0289521141630756,-0.0331041300459819,0.0803881574732746,0.414175030378984
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,15721,0.0343510438837754,0.0368787805863003,-0.0379313660653732,0.106633453832924,0.351630895300901
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,15721,0.0403345883199866,0.0241135808698975,-0.00692803018501244,0.0875972068249856,0.0944079051761069
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,15721,0.0357883455911896,0.0270375883785359,-0.0172053276307408,0.08878201881312,0.185638062853292
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,15721,0.0041759800383796,0.0417114430251935,-0.0775784482909997,0.0859304083677589,0.920253563857354
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,15721,0.0646045746240598,0.048241800446179,-0.0299493542504511,0.159158503498571,0.180530648578505
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,15721,0.0331381134130045,0.0281273703412589,-0.021991532455863,0.0882677592818719,0.238756757300739
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,15721,0.101709603372498,0.0475241529843491,0.00856226352317407,0.194856943221823,0.0323566652478803
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,15721,0.0257954979421264,0.0356360999895329,-0.044051258037358,0.0956422539216109,0.469163320624211
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),15722,0.0269518850099888,0.0485632196464895,-0.0682320254971307,0.122135795517108,0.578912448894051
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),15722,0.0067451487979201,0.0223158323297244,-0.0369938825683398,0.05048418016418,0.762459054956264
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),15722,-0.0115914386830799,0.0334776472114469,-0.0772076272175158,0.0540247498513561,0.729163893234851
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,15724,0.0393249293393603,0.0562078256122936,-0.0708424088607352,0.149492267539456,0.48416600166642
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20600.Liking for adding salt to foods,18192,-5.40636813372847e-05,0.0236631443808557,-0.0464338266678144,0.0463256993051398,0.998177083109808
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20601.Liking for aniseed,18192,-0.033025864351543,0.0237499423580281,-0.079575751373278,0.0135240226701921,0.164374078427389
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20602.Liking for apple juice,18192,0.0816728945125956,0.0237190350953696,0.0351835857256712,0.12816220329952,0.000575854414765882
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20603.Liking for apples,18192,-0.0457707889211714,0.0244544037261008,-0.0937014202243289,0.00215984238198614,0.0612671093677921
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20604.Liking for asparagus,18192,-0.0681938856024872,0.0240997216546466,-0.115429340045594,-0.0209584311593799,0.00466493810496497
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20605.Liking for aubergine,18192,-0.0987080051130705,0.0238265102834287,-0.145407965268591,-0.0520080449575502,3.44672212537902e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20606.Liking for avocados,18192,-0.0456454267458435,0.0240053122373215,-0.0926958387309937,0.00140498523930663,0.0572560329117564
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20607.Liking for bacon,18192,0.0275882702487921,0.0241382997694942,-0.0197227972994165,0.0748993377970007,0.253084722936149
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20608.Liking for baked or steamed fish,18192,-0.0555910511594834,0.0241976986680512,-0.103018540548864,-0.00816356177010309,0.021609021117657
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20609.Liking for bananas,18192,0.0212332688866355,0.0245204172913179,-0.0268267490043477,0.0692932867776186,0.386533186513126
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20610.Liking for barbequed or grilled meat,18192,-0.0283245125684538,0.023876231968524,-0.0751219272267609,0.0184729020898533,0.235517067629459
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20611.Liking for beef steak,18192,0.00688615843631551,0.0240063481960787,-0.0401662840279987,0.0539386009006297,0.774232442301464
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20612.Liking for beetroot,18192,-0.024878150000065,0.024289733182445,-0.0724860270376572,0.0227297270375272,0.305742687561273
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20613.Liking for bell pepper,18192,-0.0492389873878594,0.0239547973093624,-0.0961903901142097,-0.00228758466150911,0.0398453920676244
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20614.Liking for bicycling,18192,-0.0232902580812553,0.0239654999102319,-0.0702626379053098,0.0236821217427993,0.331150841636456
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20615.Liking for biscuits,18192,0.0452638048581105,0.0240395216287095,-0.00185365753416007,0.092381267250381,0.0597310698699481
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20616.Liking for bitter foods,18192,-0.0500628275314959,0.0237910829564704,-0.0966933501261779,-0.00343230493681396,0.0353687303238054
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20617.Liking for bitter or ale,18192,-0.0249220119830949,0.0243543579508035,-0.0726565535666697,0.0228125296004799,0.306175815132739
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20618.Liking for black olives,18192,-0.0994651272433422,0.023851773597864,-0.146214603495156,-0.0527156509915286,3.05830568821951e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20619.Liking for black pepper,18192,-0.0477982651118282,0.0240767101335881,-0.0949886169736608,-0.000607913249995526,0.0471317834170181
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20620.Liking for blue cheese,18192,0.00836261258508716,0.0238821016716115,-0.0384463066912714,0.0551715318614457,0.726220927726031
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20621.Liking for bolognese sauce,18192,0.0288797561329235,0.0239850468457493,-0.0181309356847451,0.0758904479505921,0.228576908243164
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20622.Liking for broad beans,18192,-0.0248165394662885,0.023934749105403,-0.0717286477128784,0.0220955687803014,0.299823562980732
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20623.Liking for broccoli,18192,-0.0369044854183931,0.0245926003376314,-0.0851059820801505,0.0112970112433644,0.133467700319816
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20624.Liking for brown rice,18192,-0.00261562713012848,0.0238991689172176,-0.049457998207875,0.044226743947618,0.912851329761978
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20625.Liking for brussel sprouts,18192,-0.00884120567813347,0.0241710108013086,-0.0562163868486983,0.0385339754924314,0.714535561114485
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20626.Liking for burgers (meat),18192,-0.00865727284407929,0.023809279891838,-0.0553234614320818,0.0380089157439233,0.716154097964349
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20627.Liking for burn of spicy foods,18192,-0.0187424113392915,0.0238246473058254,-0.0654387200587092,0.0279538973801263,0.431478546341254
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20628.Liking for butter on bread,18192,0.0359451651780222,0.0242980896141403,-0.0116790904656928,0.0835694208217371,0.139066482400409
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20629.Liking for butternut squash,18192,-0.0910322435856784,0.0237769852233204,-0.137635134623386,-0.0444293525479704,0.000129313737643397
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20630.Liking for cabbage,18192,-0.00692199906826987,0.0243040536253068,-0.0545579441738711,0.0407139460373314,0.775794168511992
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20631.Liking for cake,18192,0.0597086360215389,0.0240219812190375,0.0126255528322254,0.106791719210852,0.0129428527293023
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20632.Liking for cake icing,18192,0.0420529651907081,0.0236888782972209,-0.00437723627184483,0.0884831666532611,0.0758783428927441
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20633.Liking for capers,18192,-0.0904043238464728,0.0236796290447445,-0.136816396774172,-0.0439922509187736,0.000135088495623348
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20634.Liking for cauliflower,18192,-0.0368104455919246,0.0242125089017408,-0.0842669630393367,0.0106460718554874,0.128451248979703
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20635.Liking for cereal or granola bar,18192,0.0284123696215512,0.0236625516936734,-0.0179662316980486,0.0747909709411511,0.229871050341096
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20636.Liking for cheesecake,18192,0.0652253889115626,0.0238646594878687,0.01845065631534,0.112000121507785,0.0062794878375765
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20637.Liking for cherries,18192,-0.013591371812798,0.0251450285243442,-0.0628756277205126,0.0356928840949165,0.58884561885542
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20638.Liking for chicken,18192,-0.0067783905997745,0.0251079196407661,-0.0559899130956761,0.0424331318961272,0.787186229990389
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20639.Liking for chilli pepper,18192,-0.056091031773738,0.0237731505856894,-0.102686406921689,-0.00949565662578687,0.0183136610794848
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20640.Liking for chips or french fries,18192,0.0306049490914326,0.0240482224344831,-0.0165295668801543,0.0777394650630195,0.203158865559899
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20641.Liking for cigarette smoking,18192,-0.00567982615059856,0.0388477250252481,-0.0818213672000848,0.0704617148988877,0.883759260030855
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20642.Liking for cod,18192,-0.0115377580436772,0.0247297344768236,-0.0600080376182515,0.036932521530897,0.640824554768565
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20643.Liking for coffee with sugar,18192,0.0338961933440146,0.0259783125573539,-0.017021299268399,0.0848136859564282,0.191981534496975
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20644.Liking for coffee without sugar,18192,-0.0633803040665757,0.024244263419502,-0.1108990603688,-0.0158615477643519,0.00895001796914702
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20645.Liking for coriander,18192,-0.0563274882718656,0.0237834092256932,-0.102942970354224,-0.00971200618950688,0.0178779239171759
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20646.Liking for corn flakes,18192,0.0683541152249524,0.0238577359226947,0.0215929528164708,0.115115277633434,0.00417393419458406
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20647.Liking for cream,18192,0.0634604865952435,0.023724369207181,0.0169607229491687,0.109960250241318,0.00748168683306553
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20648.Liking for croissant,18192,0.0258900955391608,0.0239831645003022,-0.0211169068814315,0.0728970979597532,0.280374217889933
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20649.Liking for cucumber,18192,-0.0259148087997619,0.024003370407077,-0.0729614147976329,0.0211317971981091,0.280320380034204
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20650.Liking for curry,18192,-0.0493061356433613,0.0241718592234436,-0.0966829797213108,-0.00192929156541176,0.0413831280214943
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20651.Liking for dairy products,18192,0.0670327490581666,0.0244130127674878,0.0191832440338906,0.114882254082443,0.00604267028351991
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20652.Liking for dark chocolate,18192,-0.0422670376393729,0.0241859145127126,-0.0896714300842895,0.00513735480554378,0.0805521178053858
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20653.Liking for diet fizzy drinks,18192,-0.000795979046393151,0.0245078293800437,-0.0488313246312788,0.0472393665384925,0.974090769123914
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20654.Liking for dried fruit,18192,-0.0234795644183852,0.0241098576287063,-0.0707348853706495,0.0237757565338792,0.330140289334056
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20655.Liking for eggs,18192,0.00274010161720049,0.0246533146901542,-0.0455803951755018,0.0510605984099028,0.911502304552092
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20656.Liking for exercising alone,18192,-0.039256121329512,0.023815649466216,-0.0859347942832954,0.00742255162427134,0.0993016430797666
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20657.Liking for exercising with others,18192,-0.0171322059439603,0.0239245206018741,-0.0640242663236336,0.029759854435713,0.4739425042084
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20658.Liking for extra virgin olive oil,18192,-0.0371570589698199,0.0243164907893474,-0.0848173809169408,0.0105032629773009,0.12651502848873
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20659.Liking for fatty foods,18192,0.0286921911584075,0.0237541145758978,-0.0178658734103522,0.0752502557271671,0.227107991822758
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20660.Liking for fresh tomatoes,18192,-0.0545703872675247,0.0256011889192567,-0.104748717549268,-0.00439205698578163,0.0330566811502811
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20661.Liking for fried chicken,18192,0.0347943654804338,0.0236584363059959,-0.0115761696793181,0.0811649006401857,0.141390690493051
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20662.Liking for fried or battered fish,18192,0.0242941378912144,0.0239857636459029,-0.0227179588547553,0.0713062346371842,0.311142171065876
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20663.Liking for fruit,18192,-0.0333478457168215,0.0265534197878107,-0.0853925485009304,0.0186968570672874,0.209176492124426
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20664.Liking for garlic,18192,-0.0338559328376252,0.0240660266359179,-0.0810253450440243,0.0133134793687739,0.159505697935855
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20665.Liking for gherkins,18192,-0.0317227024271212,0.0237741284707099,-0.0783199942297126,0.0148745893754703,0.182110115768007
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20666.Liking for globe artichoke,18192,-0.0582266750302721,0.0238274524121281,-0.104928481758043,-0.011524868302501,0.0145477512718126
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20667.Liking for goat's cheese,18192,-0.0549222606057326,0.0237664507804701,-0.101504504135454,-0.00834001707601116,0.0208486590513719
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20668.Liking for going to a cafe,18192,-0.0285969205757844,0.0240548485121695,-0.0757444236596365,0.0185505825080677,0.234525461461302
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20669.Liking for going to the gym,18192,-0.00471940444003643,0.0236437387144094,-0.0510611323202789,0.0416223234402061,0.841791883969698
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20670.Liking for going to the pub,18192,-0.0107103699504526,0.0237431831833077,-0.0572470089897357,0.0358262690888305,0.651928324401387
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20671.Liking for grapefruit,18192,-0.0390049226630355,0.0239472629711356,-0.0859415580864613,0.00793171276039022,0.103376055563476
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20672.Liking for green olives,18192,-0.0753845800244271,0.0239572410105366,-0.122340772405079,-0.0284283876437753,0.00165430369085234
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20673.Liking for haddock,18192,-0.0608983567493657,0.0244726613869312,-0.108864773067751,-0.0129319404309806,0.0128399547492781
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20674.Liking for ham,18192,0.040840879522316,0.0240823136417384,-0.00636045521549126,0.0880422142601233,0.0899244386123536
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20675.Liking for hard cheese,18192,0.022730524899933,0.0245147203798093,-0.0253183270444933,0.0707793768443593,0.353824936491613
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20676.Liking for herring,18192,-0.0150629146010947,0.0237320702424505,-0.0615777722762976,0.0314519430741082,0.52562742330868
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20677.Liking for honey,18192,0.0280941897940688,0.0238131551786399,-0.0185795943560653,0.0747679739442029,0.238104750311722
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20678.Liking for horseradish or wasabi,18192,-0.0339551052308409,0.0238607013895317,-0.0807220799543231,0.0128118694926413,0.154737201618955
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20679.Liking for ice cream,18192,0.05595622997581,0.0240506268177346,0.00881700141305021,0.10309545853857,0.0199974104156358
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20680.Liking for jam,18192,0.0387174906788212,0.0238360050584796,-0.00800107923579885,0.0854360605934412,0.104323168419869
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20681.Liking for kiwi fruit,18192,-0.00688294738012678,0.0241054369112501,-0.0541296037261769,0.0403637089659234,0.775237502608517
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20682.Liking for lager,18192,-0.0674520025488745,0.023883301044828,-0.114263272596737,-0.0206407325010116,0.00474455425950388
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20683.Liking for lamb,18192,0.0183479532236025,0.0241874293770838,-0.0290594083554817,0.0657553148026867,0.448117315835342
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20684.Liking for lemons,18192,-0.0536417846647241,0.0239841977671161,-0.100650812288272,-0.00663275704117649,0.0253280500442749
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20685.Liking for lentils or beans,18192,-0.0544619580688958,0.0240857642462481,-0.101670055991542,-0.00725386014624954,0.0237606328329929
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20686.Liking for liver,18192,0.0479822106215787,0.0239288193861916,0.00108172462464327,0.0948826966185142,0.0449558400341818
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20687.Liking for mackerel,18192,-0.0425871398718138,0.0239124040027602,-0.0894554517172237,0.00428117197359611,0.0749349716220154
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20688.Liking for marzipan,18192,-0.0127318555224369,0.0236982720043175,-0.0591804686508992,0.0337167576060254,0.591102715265154
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20689.Liking for mayonnaise,18192,-0.0333741732695691,0.0240539222681102,-0.0805198609150651,0.013771514375927,0.165314524852369
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20690.Liking for melon,18192,0.00145628823924885,0.0247025617641773,-0.0469607328185387,0.0498733092970364,0.952990252628571
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20691.Liking for milk chocolate,18192,0.0659603039802984,0.0240458771926091,0.0188303846827846,0.113090223277812,0.00609213495161265
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20692.Liking for mushrooms,18192,-0.0233182272392565,0.0246433029780135,-0.0716191010761629,0.0249826465976499,0.344043981920116
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20694.Liking for orange juice,18192,0.0574063836320803,0.0238195732892239,0.0107200199852014,0.104092747278959,0.0159601676485243
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20695.Liking for oranges,18192,-0.0292686993339793,0.0244525015320324,-0.0771956023367628,0.0186582036688043,0.231337235546505
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20696.Liking for pasta,18192,0.00157196052400956,0.0241186040514369,-0.0457005034168068,0.0488444244648259,0.948034375950578
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20697.Liking for pears,18192,-0.00367040874467221,0.0244956234618448,-0.051681830729888,0.0443410132405436,0.88089301176868
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20698.Liking for pizza,18192,-0.0159650838920353,0.0239019570290433,-0.0628129196689603,0.0308827518848896,0.504180091064855
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20699.Liking for plain yogurt,18192,-0.0152847644408953,0.0240311831014632,-0.062385883319763,0.0318163544379725,0.524759156069281
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20700.Liking for plums,18192,-0.022933535238538,0.0244339136267393,-0.0708240059469472,0.0249569354698711,0.347951490329984
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20701.Liking for pollock,18192,-0.0344898589378311,0.0237901184802369,-0.0811184911590955,0.0121387732834333,0.147143928478016
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20702.Liking for pork chop,18192,0.0269368545829093,0.0238347340324676,-0.0197792241207272,0.0736529332865457,0.258427414348891
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20703.Liking for porridge,18192,-0.0033089309649899,0.0243160061419998,-0.0509683030033095,0.0443504410733297,0.891759258046203
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20704.Liking for potato crisps,18192,0.025388303233309,0.0240292522256671,-0.0217090311289986,0.0724856375956166,0.290727318526752
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20705.Liking for potatoes,18192,0.0250664519345019,0.0243022271529283,-0.0225659132852376,0.0726988171542414,0.302345120762231
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20706.Liking for prawns,18192,-0.0297034509113945,0.0242683153792138,-0.0772693490546535,0.0178624472318644,0.22098313243879
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20707.Liking for raw carrots,18192,-0.0161049660311478,0.0241871553971765,-0.0635117906096138,0.0313018585473183,0.505516793531406
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20708.Liking for red meat,18192,-0.0210414355586672,0.0240465000556689,-0.0681725756677783,0.0260897045504439,0.381568547223592
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20709.Liking for red wine,18192,-0.0503778318242491,0.0240683861805658,-0.097551868738158,-0.00320379491034024,0.0363529752803919
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,18192,0.0543961193537466,0.0245733125010356,0.00623242685171677,0.102559811855776,0.0268669021794602
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20711.Liking for roast chicken,18192,0.028074211304299,0.0251542649679652,-0.0212281480329127,0.0773765706415107,0.264401984445907
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20712.Liking for salad dressing,18192,-0.037383850976553,0.0238991108246136,-0.0842261081927957,0.00945840623968975,0.117779557307982
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20713.Liking for salad leaves,18192,-0.0733244355416069,0.0244666338497462,-0.12127903788711,-0.0253698331961043,0.00273094604559477
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20714.Liking for salami,18192,-0.0334689283529481,0.023881595177588,-0.0802768549010206,0.0133389981951244,0.161095794767767
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20715.Liking for salmon,18192,-0.0868312602473048,0.0249075275349531,-0.135650014215813,-0.0380125062787967,0.00049119143109085
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20716.Liking for salty foods,18192,0.0259861986364747,0.0237145073596298,-0.0204942357883997,0.072466633061349,0.273183759135195
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20717.Liking for salty pretzels,18192,-0.00410818007074814,0.0237885844910318,-0.0507338056731704,0.0425174455316741,0.862892751718427
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20718.Liking for sardines,18192,-0.0218872823899742,0.0237213828068358,-0.0683811926913724,0.024606627911424,0.356185432748399
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20719.Liking for sausages (meat),18192,0.0109255620369332,0.0238372186917229,-0.0357953865988438,0.0576465106727102,0.646713334463325
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20720.Liking for savoury biscuits,18192,0.0387455611428038,0.024047215775629,-0.00838698177742916,0.0858781040630367,0.107147282529625
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20721.Liking for shellfish (other than prawns),18192,-0.0386357894393523,0.0237811545970739,-0.085246852449617,0.00797527357091244,0.104256863627207
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20722.Liking for skimmed milk,18192,0.00548890478177116,0.0238766835950967,-0.0413093950646183,0.0522872046281606,0.818183285124497
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20723.Liking for smoked fish,18192,-0.0533662804416376,0.023969225113701,-0.100345961664492,-0.00638659921878374,0.025996269385554
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20724.Liking for soft cheese,18192,0.0526813499912933,0.0238318881302414,0.00597084925602016,0.0993918507265665,0.0270800963768705
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20725.Liking for soy sauce,18192,-0.0356651476657264,0.023837481577534,-0.0823866115576931,0.0110563162262402,0.134624293903376
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20726.Liking for soya milk,18192,-0.0496243798230457,0.0239538530997026,-0.0965739318984628,-0.00267482774762867,0.0383106905506669
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20727.Liking for spicy foods,18192,-0.0391585347596613,0.0238694551619167,-0.085942666877018,0.00762559735769543,0.100912522082438
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20728.Liking for spinach,18192,-0.0349215906951067,0.0239955569663859,-0.0819528823492232,0.0121097009590097,0.145593624781274
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20729.Liking for spirits,18192,-0.0273831439032884,0.0238517548585566,-0.0741325834260592,0.0193662956194825,0.250960672282083
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20730.Liking for strawberries,18192,0.013939905474446,0.0261568785693878,-0.0373275765215541,0.0652073874704462,0.594085374814641
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20731.Liking for sweet coffee house drinks,18192,0.0405491073265026,0.0244351957017709,-0.00734387624896837,0.0884420909019736,0.0970414027813737
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20732.Liking for sweet foods,18192,0.0811809085928178,0.0238274422181188,0.0344791218453049,0.127882695340331,0.000658152284921931
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20733.Liking for taking the stairs,18192,-0.0369256547732041,0.0244594818900323,-0.0848662392776675,0.0110149297312592,0.131145991571234
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20734.Liking for tea with sugar,18192,0.0618220758090681,0.0287231790313085,0.00552464490770357,0.118119506710433,0.0313836362691718
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20735.Liking for tea without sugar,18192,-0.025978798846565,0.0249910136612365,-0.0749611856225886,0.0230035879294586,0.29857418447168
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20736.Liking for tomato ketchup,18192,0.0295234454232018,0.0237669771032077,-0.0170598296990852,0.0761067205454889,0.214177160539012
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20737.Liking for tinned tuna,18192,-0.0375509338880849,0.024015681222416,-0.0846216690840202,0.00951980130785048,0.117928806800509
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20738.Liking for turnip (white),18192,-0.0428233155860244,0.0238807791287098,-0.0896296426782956,0.00398301150624675,0.0729555515047663
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20739.Liking for vegetables,18192,-0.0133339548476068,0.0263638998334682,-0.0650071985212044,0.0383392888259908,0.613027313293094
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20740.Liking for vinegar,18192,-0.0349336738996907,0.0238241098416625,-0.0816289291893492,0.0117615813899678,0.142579519861443
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20741.Liking for watching television,18192,0.0115804078989795,0.0241243599319506,-0.0357033375676436,0.0588641533656026,0.631212093427683
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20742.Liking for whisky,18192,-0.0183024537980784,0.0248765189996761,-0.0670604310374437,0.0304555234412868,0.461903242199312
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20743.Liking for white bread,18192,0.0180737396393858,0.0236711276688621,-0.0283216705915839,0.0644691498703555,0.445154181101304
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20744.Liking for white rice,18192,-0.00378247261659275,0.0239844862018724,-0.0507920655722626,0.0432271203390771,0.874691038502929
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20745.Liking for white wine,18192,-0.024517867679904,0.023742416074685,-0.0710530031862867,0.0220172678264786,0.301776304910059
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,18192,0.0243519229950773,0.0241225022992093,-0.022928181511373,0.0716320275015276,0.312743239897929
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20747.Liking for whole milk,18192,0.0457536201150885,0.0237204865938088,-0.000738533608776702,0.0922457738389538,0.0537631620642156
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20748.Liking for wholemeal bread,18192,-0.0175976520615417,0.024930927744187,-0.0664622704401482,0.0312669663170649,0.480286564835128
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X20749.Liking for working up a sweat,18192,-0.0429548137780107,0.0239892307574006,-0.0899737060625158,0.00406407850649441,0.0733761766698752
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X21001.Body mass index (BMI),50058,0.0582677833267036,0.010735779455633,0.0372256555936628,0.0793099110597443,5.74334628480394e-08
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X21002.Weight,50098,-0.0294006276529768,0.0060517582979063,-0.0412620739168732,-0.0175391813890805,1.18817437311031e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X21021.Pulse wave Arterial Stiffness index,16673,0.0111028049577287,0.00438957356272509,0.00249924077478749,0.0197063691406698,0.0114362705974152
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,17396,0.0218488234841149,0.0255747907385487,-0.0282777663634405,0.0719754133316704,0.392944504983155
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,17413,0.0104584540981862,0.0266666634018354,-0.0418082061694111,0.0627251143657835,0.694921102673651
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,17415,-0.0352399089235849,0.0262411805862753,-0.0866726228726845,0.0161928050255146,0.179314131110008
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21040.Satisfaction with bowel habits,17341,-0.0208132362601633,0.0243085044132772,-0.0684579049101866,0.0268314323898599,0.391892302657702
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,17319,-0.00734414254010172,0.0261190104152537,-0.0585374029539989,0.0438491178737955,0.778575731047592
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21042.Greatest number of times bowels opened per day,17329,0.0449490413209219,0.0264562873944834,-0.00690528197226545,0.0968033646141093,0.0893385086760606
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21043.Least number of times bowels opened per week,17209,0.0288290339037922,0.0262234705008058,-0.0225689682777871,0.0802270360853716,0.271626473758033
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21044.Average number of times bowels opened per day,17266,0.0445254857892564,0.0292713318447881,-0.0128463246265283,0.101897296205041,0.128245683284529
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,17424,0.00357528514944779,0.0264082782955831,-0.0481849403098951,0.0553355106087907,0.892309036701563
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,17414,-0.0141595616027962,0.0267048604864981,-0.0665010881563325,0.03818196495074,0.595963304374353
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,9798,0.0612982572488796,0.0417800005439608,-0.0205905438172835,0.143187058315043,0.142362651955381
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,17419,-0.00238155091597042,0.0289611559940995,-0.0591454166644055,0.0543823148324647,0.934462702424287
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,17416,0.0176126654224032,0.040363840058019,-0.0615004610913141,0.0967257919361205,0.662589952275323
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,17417,0.00215300760908377,0.0313271874194519,-0.059248279733042,0.0635542949512096,0.945208122315338
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,17416,0.037918987563375,0.0780331984364663,-0.115026081372099,0.190864056498849,0.627020049899688
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,17423,0.0458155741459625,0.0306404879815467,-0.014239782297869,0.105870930589794,0.134864062192334
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,17420,-0.0263527716502961,0.0302461066689211,-0.0856351407213815,0.0329295974207894,0.383614319159711
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,17023,0.0188373685763958,0.0275540335729933,-0.035168537226671,0.0728432743794626,0.494204290597451
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,17413,0.0076297274507516,0.0271953067200318,-0.0456730737205107,0.0609325286220139,0.779056532701463
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,17420,-0.00363512025456824,0.0395614683959534,-0.0811755983106369,0.0739053578015004,0.926790170927941
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,17423,0.0100446808148509,0.0265464684893016,-0.0419863974241803,0.0620757590538821,0.705152152097779
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,17420,-0.00245717776182863,0.0266324513691493,-0.0546567824453612,0.0497424269217039,0.92649050744169
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X21100.Water hardness (USGS classification),49791,0.0773293189414733,0.0156237405375863,0.0467067874878041,0.107951850395142,7.46564369990553e-07
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X2139.Age first had sexual intercourse,43426,0.00119856658579236,0.00276540408185803,-0.00422162541464939,0.0066187585862341,0.664715727707818
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X2149.Lifetime number of sexual partners,40274,-0.031039355895359,0.0175645434882305,-0.0654658611322908,0.00338714934157275,0.0772090377549111
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X22032.IPAQ activity group,40276,-0.0836973763716128,0.017192575647913,-0.117394824641522,-0.0499999281017034,1.13029419950138e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X22033.Summed days activity,41337,-0.0143045440593737,0.00270069235377204,-0.0195979010727669,-0.00901118704598045,1.18567573006122e-07
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X22034.Summed minutes activity,40276,-0.011276726214032,0.00271868254778232,-0.0166053440076853,-0.00594810842037863,3.36278861276711e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X22037.MET minutes per week for walking,38556,-0.0107670277771319,0.00276263248895895,-0.0161817874554914,-0.00535226809877235,9.74034742297089e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X22038.MET minutes per week for moderate activity,40276,-0.00939720531535201,0.0027256435116074,-0.0147394665981025,-0.00405494403260151,0.000565956050833899
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X22039.MET minutes per week for vigorous activity,40276,-0.0704134486257693,0.017196827928213,-0.104119231365067,-0.0367076658864717,4.23795478351709e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X22040.Summed MET minutes per week for all activity,38556,-0.0119370095442757,0.00277532149730141,-0.0173766396789865,-0.00649737940956494,1.70349450135131e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X2217.Age started wearing glasses or contact lenses,42749,-0.00125339349139408,0.00269182728622168,-0.00652937497238858,0.00402258798960042,0.641483282988497
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X22501.Year ended full time education,12221,-0.00734687685054067,0.0122702291949234,-0.0313965260725905,0.0167027723715091,0.549346527777759
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X22506.Tobacco smoking,12141,0.0943172434719348,0.063904019835463,-0.0309346354055726,0.219569122349442,0.139991242839001
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,46990,0.010006193154599,0.040846193554218,-0.0700523462116684,0.0900647325208663,0.806478813450189
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23098.Weight,49249,-0.0275318192800929,0.00610742773341969,-0.0395023776375955,-0.0155612609225903,6.56157327121147e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23099.Body fat percentage,49221,0.0604881145462761,0.00585290276565451,0.0490164251255932,0.0719598039669589,5.20647036335582e-25
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23100.Whole body fat mass,49172,0.031164347738931,0.00565685569864351,0.0200769105695898,0.0422517849082723,3.6241657284518e-08
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23101.Whole body fat-free mass,49243,-0.0511951947559698,0.0051037564112656,-0.0611985573220503,-0.0411918321898892,1.17506620913483e-23
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23102.Whole body water mass,49249,-0.0514637015200241,0.00511000323330779,-0.0614793078573074,-0.0414480951827409,7.81405549691913e-24
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23104.Body mass index (BMI),49249,0.0596665289114075,0.0107997121064545,0.0384990931827568,0.0808339646400583,3.31477257980724e-08
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23105.Basal metabolic rate,49247,-0.0517048550194185,0.00546141070035764,-0.0624092199921195,-0.0410004900467175,2.99361441592506e-21
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23106.Impedance of whole body,49244,0.0456598349629164,0.00417575898201514,0.0374753473581667,0.0538443225676661,8.48684582871782e-28
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23107.Impedance of leg (right),49246,0.0461226900558655,0.00340632803906487,0.0394462870992984,0.0527990930124327,1.07407190954032e-41
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23108.Impedance of leg (left),49245,0.0436510097859183,0.00338394495675021,0.0370184776706879,0.0502835419011487,5.22507619384112e-38
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23109.Impedance of arm (right),49236,0.0250759054429105,0.00416529937524378,0.0169119186674326,0.0332398922183883,1.75438776299717e-09
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23110.Impedance of arm (left),49244,0.0228194049671554,0.0041705333970719,0.0146451595088945,0.0309936504254163,4.48210637080209e-08
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23111.Leg fat percentage (right),49245,0.0828083187307791,0.00708013811500017,0.0689312480253788,0.0966853894361795,1.47338987102221e-31
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23112.Leg fat mass (right),49244,0.0474663594678608,0.00753639802110445,0.0326950193464961,0.0622376995892256,3.03496983959996e-10
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23113.Leg fat-free mass (right),49243,-0.0619723087791074,0.00533785836307172,-0.072434511170728,-0.0515101063874869,4.02731901719785e-31
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23114.Leg predicted mass (right),49242,-0.062160855630489,0.00536430813549018,-0.0726748995760498,-0.0516468116849283,5.20997601609042e-31
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23115.Leg fat percentage (left),49239,0.0816999134159301,0.00737905934640388,0.0672369570969785,0.0961628697348817,1.85628099787994e-28
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23116.Leg fat mass (left),49239,0.046223653813164,0.00786076061784501,0.0308165630021878,0.0616307446241403,4.12152358133046e-09
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23117.Leg fat-free mass (left),49236,-0.0592756621560546,0.00557721992922957,-0.0702070132173445,-0.0483443110947646,2.35386362765099e-26
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23118.Leg predicted mass (left),49235,-0.0592037388544654,0.00560556783305136,-0.070190651807246,-0.0482168259016847,4.78749496936695e-26
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23119.Arm fat percentage (right),49235,0.0447159166878229,0.00650042452620695,0.0319750846164573,0.0574567487591886,6.10253292702653e-12
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23120.Arm fat mass (right),49230,0.0258487634103586,0.00644316032269766,0.0132201691778712,0.038477357642846,6.03428422315852e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23121.Arm fat-free mass (right),49231,-0.0328818767621527,0.00514154371663434,-0.042959302446756,-0.0228044510775494,1.61632082242959e-10
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23122.Arm predicted mass (right),49230,-0.0332257535384884,0.00514866100167292,-0.0433171291017673,-0.0231343779752095,1.10468707860678e-10
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23123.Arm fat percentage (left),49225,0.0427827381224377,0.00667196272870351,0.0297056911741789,0.0558597850706966,1.4462006836037e-10
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23124.Arm fat mass (left),49224,0.0236050365187669,0.00642938372300426,0.0110034444216785,0.0362066286158553,0.000241451526545614
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23125.Arm fat-free mass (left),49220,-0.030035079000667,0.00524094880806279,-0.04030733866447,-0.0197628193368639,1.00512021967463e-08
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23126.Arm predicted mass (left),49217,-0.0292496503262994,0.00525708567941433,-0.0395535382579515,-0.0189457623946473,2.6525252672547e-08
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23127.Trunk fat percentage,49213,0.0345127765245155,0.00420121762902811,0.0262783899716204,0.0427471630774106,2.17372274083372e-16
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23128.Trunk fat mass,49209,0.0215542642915685,0.00462499913054997,0.0124892659956905,0.0306192625874464,3.16448495744835e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23129.Trunk fat-free mass,49202,-0.042880321562077,0.00462976543475142,-0.0519546618141898,-0.0338059813099642,2.08694581568952e-20
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X23130.Trunk predicted mass,49197,-0.0430263590117544,0.00463149225699275,-0.0521040838354602,-0.0339486341880487,1.60440742910404e-20
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23400.Total Cholesterol,28797,0.0299320009088811,0.00335694973993132,0.0233523794186157,0.0365116223991465,5.09393055377151e-19
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,28797,0.0431237568461058,0.00324844904466783,0.0367567967185568,0.0494907169736547,4.23157076492128e-40
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",28797,0.0509899889681208,0.00325064899210808,0.0446187169435889,0.0573612609926526,3.18968966293019e-55
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23403.VLDL Cholesterol,28797,0.0727764579287435,0.00324529263239886,0.0664156843692418,0.0791372314882453,1.97539460052219e-110
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23404.Clinical LDL Cholesterol,28797,0.0265480794712905,0.00325880977454837,0.0201608123131757,0.0329353466294053,3.89456605128149e-16
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23405.LDL Cholesterol,28797,0.0343560967374013,0.00324693407594356,0.0279921059485519,0.0407200875262507,4.07316866529115e-26
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23406.HDL Cholesterol,28797,-0.0402972202057958,0.00377720830242185,-0.0477005484785426,-0.032893891933049,1.60168527038681e-26
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23407.Total Triglycerides,28797,0.105679175764678,0.00341507317472771,0.0989856323422119,0.112372719187145,7.31921961710918e-207
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23408.Triglycerides in VLDL,28797,0.103849461459337,0.00344287402747057,0.0971014283654947,0.110597494553179,8.26586834535564e-197
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23409.Triglycerides in LDL,28797,0.0962731137404208,0.00331720594481033,0.0897713900885925,0.102774837392249,1.47105757314259e-182
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23410.Triglycerides in HDL,28797,0.0938924750430715,0.00330190981352962,0.0874207318085535,0.10036421827759,1.95173902744335e-175
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,28797,0.0506464017201637,0.00339884295749456,0.0439846695234744,0.0573081339168531,4.98524395218731e-50
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23412.Phospholipids in VLDL,28797,0.0907956128849237,0.00330843900247322,0.0843110724400762,0.0972801533297712,1.06277122202363e-163
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23413.Phospholipids in LDL,28797,0.0359353385876411,0.00323931666450303,0.0295862779252152,0.0422843992500671,1.54151082114766e-28
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23414.Phospholipids in HDL,28797,-0.000618401951994817,0.00364984443114523,-0.00777209703703947,0.00653529313304983,0.86545772021207
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23415.Total Esterified Cholesterol,28797,0.0257441328946975,0.00337488778601438,0.0191293528341094,0.0323589129552857,2.45500007846532e-14
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,28797,0.0634943428200418,0.00323268220048023,0.0571582857071006,0.0698303999329831,2.48357464567324e-85
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23417.Cholesteryl Esters in LDL,28797,0.0412847172922033,0.00323753940353381,0.034939140061277,0.0476302945231296,3.83627174629832e-37
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23418.Cholesteryl Esters in HDL,28797,-0.0467537374531546,0.00376245010024474,-0.0541281396496343,-0.0393793352566749,2.31572191092604e-35
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23419.Total Free Cholesterol,28797,0.0396106895597047,0.00331395214718103,0.0331153433512299,0.0461060357681796,7.51782257431481e-33
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23420.Free Cholesterol in VLDL,28797,0.0838419652455697,0.00328155511749785,0.0774101172152739,0.0902738132758655,2.15749224885994e-142
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23421.Free Cholesterol in LDL,28797,0.0144149648035211,0.00328461808471229,0.00797711335748497,0.0208528162495571,1.14473859878541e-05
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23422.Free Cholesterol in HDL,28797,-0.0158256622012645,0.0037815684408513,-0.023237536345333,-0.00841378805719594,2.86078999892229e-05
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,28797,0.0626318474475735,0.00327409344320254,0.0562146242988966,0.0690490705962505,4.57209664868595e-81
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23424.Total Lipids in VLDL,28797,0.0967847755792287,0.00334686961642802,0.0902249111310297,0.103344640027428,2.78511869172512e-181
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23425.Total Lipids in LDL,28797,0.0396891494464554,0.0032403289989283,0.0333381046085559,0.0460401942843548,2.08496177394532e-34
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23426.Total Lipids in HDL,28797,-0.0103873934773207,0.00370090460019444,-0.0176411664937018,-0.00313362046093954,0.00500827497629468
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,28797,0.014769332504807,0.00347016668306349,0.00796780580600255,0.0215708592036114,2.08693353180569e-05
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23428.Concentration of VLDL Particles,28797,0.0818767303967467,0.00326775215706989,0.0754719361688897,0.0882815246246037,4.43600913603728e-137
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23429.Concentration of LDL Particles,28797,0.0441412461135634,0.00323020511073853,0.0378100440965159,0.0504724481306109,2.22385993601043e-42
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23430.Concentration of HDL Particles,28797,0.00668087987061076,0.00348376880093738,-0.000147306979226513,0.013509066720448,0.0551568911760304
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23431.Average Diameter for VLDL Particles,28797,0.094952251524816,0.00358827876713944,0.0879192251412227,0.101985277908409,1.78597589815072e-152
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23432.Average Diameter for LDL Particles,28797,-0.0392114335691447,0.0033897050421993,-0.0458552554518554,-0.0325676116864341,7.0225765098701e-31
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23433.Average Diameter for HDL Particles,28797,-0.0571941860432646,0.00386537747502153,-0.0647703258943068,-0.0496180461922224,2.34266432869578e-49
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23434.Phosphoglycerides,28774,0.0508500963631661,0.00342170555793785,0.044143553469608,0.0575566392567243,9.03095268448934e-50
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,28774,0.102348297012201,0.00363595766646779,0.0952218199859245,0.109474774038478,5.32297956455497e-172
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23436.Total Cholines,28774,0.0438231248303775,0.00345519058783411,0.0370509512782226,0.0505952983825323,9.18559291591134e-37
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23437.Phosphatidylcholines,28774,0.0418860338562631,0.00347079529065843,0.0350832750865726,0.0486887926259536,1.8748042980074e-33
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23438.Sphingomyelins,28773,0.0206995575584031,0.00348516304618197,0.0138686379878864,0.0275304771289198,2.89462411935835e-09
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23439.Apolipoprotein B,28797,0.0473464500057487,0.00323259440062454,0.0410105649805246,0.0536823350309728,2.11653245387161e-48
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23440.Apolipoprotein A1,28797,-8.20532405392585e-05,0.00360264591904318,-0.00714323924186389,0.00697913276078537,0.981829248086161
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,28797,0.0423871816700296,0.00330355407903699,0.0359122156751171,0.0488621476649421,1.39779928004884e-37
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23442.Total Fatty Acids,28774,0.0876508519144845,0.00326486674867653,0.0812517130870785,0.0940499907418905,7.92617982889748e-157
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23443.Degree of Unsaturation,28774,-0.0776857740933963,0.00355126027143827,-0.0846462442254153,-0.0707253039613773,3.20715176622619e-105
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23444.Omega-3 Fatty Acids,28774,0.0246384807237965,0.00337123515312744,0.0180308598236667,0.0312461016239263,2.7728773615224e-13
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23445.Omega-6 Fatty Acids,28774,0.0555546501464292,0.0032893364770098,0.04910755065149,0.0620017496413684,1.09412706420685e-63
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,28774,0.0536037265471674,0.00330779369273209,0.0471204509094125,0.0600870021849223,8.43549011314424e-59
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23447.Monounsaturated Fatty Acids,28774,0.104227220497206,0.00333412711781739,0.0976923313462837,0.110762109648128,5.44420470709933e-211
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23448.Saturated Fatty Acids,28774,0.0922172242467416,0.00327776994100415,0.0857927951623734,0.0986416533311097,7.98499501577216e-172
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23449.Linoleic Acid,28774,0.0541043826814795,0.00327860664333224,0.0476783136605483,0.0605304517024107,6.7393788718114e-61
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23450.Docosahexaenoic Acid,28774,-0.0168799501029585,0.00346939371506216,-0.0236799617844804,-0.0100799384214367,1.14835860458546e-06
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,28774,-0.023139473818398,0.00340139039996757,-0.0298061990023345,-0.0164727486344616,1.04508772662449e-11
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,28774,-0.098235673947874,0.00349616521637182,-0.105088157771963,-0.0913831901237852,2.14196237298529e-171
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,28774,-0.111165504313819,0.0035517633531766,-0.118126960486045,-0.104204048141593,1.72482916453937e-211
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,28774,0.108740849547621,0.00361893700800226,0.101647733011937,0.115833966083306,2.45422080580201e-195
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,28774,0.0590475763318458,0.00330368671730907,0.05257235036592,0.0655228022977716,4.62334322988578e-71
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,28774,-0.0552753858106156,0.0035215399192076,-0.0621776040522625,-0.0483731675689687,2.71794072278972e-55
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,28774,-0.0736514492372119,0.00346048180760242,-0.0804339935801126,-0.0668689048943111,9.48941566396114e-100
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,28774,-0.115664928431099,0.00361301577950485,-0.122746439358929,-0.10858341750327,5.39682891009402e-221
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,28772,-0.00372061629882742,0.00336817458090287,-0.0103222384773971,0.00288100587974222,0.269325377285869
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23460.Alanine,28788,0.0396143895146556,0.00329417369824703,0.0331578090660915,0.0460709699632198,3.13253613291121e-33
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23461.Glutamine,28714,-0.0675116538712786,0.00325541636744045,-0.0738922699514618,-0.0611310377910953,7.77254700097338e-95
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23462.Glycine,28762,-0.00188955575642746,0.00346340574441811,-0.00867783101548695,0.00489871950263203,0.585360724684203
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23463.Histidine,28760,0.00141823531274801,0.00325837446868911,-0.00496817864588264,0.00780464927137866,0.663378043305386
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),28776,0.0419203016766641,0.00344502844962812,0.035168045915393,0.0486725574379352,5.55534410445399e-34
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23465.Isoleucine,28791,0.0347570864094805,0.00336236022208357,0.0281668603741967,0.0413473124447643,5.2953227513594e-25
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23466.Leucine,28792,0.0351254856183337,0.00343547877672307,0.0283919472159565,0.0418590240207109,1.69915284016191e-24
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23467.Valine,28776,0.0445799268235498,0.0034518934139882,0.0378142157321329,0.0513456379149666,4.74971569527246e-38
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23468.Phenylalanine,28786,0.0177168207664657,0.0032907250352635,0.0112669996973493,0.0241666418355822,7.34733072263432e-08
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23469.Tyrosine,28764,0.0228977253143454,0.00334930313350771,0.0163330911726703,0.0294623594560205,8.2735531257038e-12
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23470.Glucose,28742,-0.0244895565428609,0.00330752993882204,-0.0309723152229521,-0.0180067978627697,1.35580982808632e-13
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23471.Lactate,28744,0.0931485347010663,0.00324292305409868,0.0867924055150329,0.0995046638870997,6.55906895976845e-179
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23472.Pyruvate,28713,0.0303035252231183,0.0032728027471692,0.0238888318386666,0.0367182186075699,2.1989295879128e-20
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23473.Citrate,28793,0.0167324462802756,0.00332110022030647,0.0102230898484749,0.0232418027120763,4.72712797097628e-07
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23474.3-Hydroxybutyrate,28331,0.0204959762468588,0.00334383337485481,0.0139420628321433,0.0270498896615742,8.93271758498213e-10
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23475.Acetate,28772,-0.0528165101027993,0.00326293071335919,-0.0592118543009833,-0.0464211659046152,1.13556673481179e-58
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23476.Acetoacetate,28795,0.0111185820006358,0.00327570972609444,0.00469819093749074,0.0175389730637809,0.000689093226795349
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23477.Acetone,28795,-0.0248446935732567,0.00327616654184899,-0.0312659799952807,-0.0184234071512327,3.46582396108686e-14
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23478.Creatinine,28077,0.0327997209150385,0.00388732644399976,0.025180561084799,0.040418880745278,3.39270571608847e-17
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23479.Albumin,28794,0.0119735998185135,0.00332266070427898,0.00546118483812672,0.0184860147989003,0.000314347360823125
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23480.Glycoprotein Acetyls,28797,0.114753798103292,0.00342192728100953,0.108046820632514,0.121460775574071,6.81637070526732e-242
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,28797,0.103116967417067,0.00345484223625939,0.0963454766339989,0.109888458200136,8.33932641718886e-193
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,28797,0.100388030797802,0.00344924606976616,0.0936275085010604,0.107148553094544,1.44900447623892e-183
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,28797,0.104110131869383,0.00346774378090878,0.0973133540588015,0.110906909679964,5.1024624432026e-195
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,28797,0.104241231483683,0.00343472471202253,0.0975091710481186,0.110973291919247,3.5539119264788e-199
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,28797,0.103662557400157,0.00342214476358302,0.0969551536635338,0.110369961136779,1.93034698666635e-198
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,28797,0.102427957220529,0.0034377898223839,0.0956898891686563,0.109166025272401,3.8003082563683e-192
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,28797,0.0947479037578675,0.00343755738547612,0.0880102912823343,0.101485516233401,4.37012557567556e-165
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,28797,0.105942227059023,0.00346994267895395,0.0991411394082729,0.112743314709772,1.64009081783421e-201
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,28797,0.104905767594725,0.00346587100800552,0.0981126604190346,0.111698874770416,3.84616621966777e-198
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,28797,0.102874840623611,0.00344617887858311,0.0961203300215879,0.109629351225634,7.26181142060634e-193
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,28797,0.094732304345536,0.00337830591165161,0.0881108247586989,0.101353783932373,1.00766472117078e-170
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,28797,0.0864294100831811,0.00333803746694923,0.0798868566479606,0.0929719635184016,3.84491905406616e-146
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,28797,0.100306564497045,0.00341874059142663,0.0936058329378484,0.107007296056241,1.78029899408522e-186
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,28797,0.106076519325404,0.00349815627842849,0.0992201330196838,0.112932905631123,7.56541212627759e-199
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23495.Concentration of Large VLDL Particles,28797,0.100919747549894,0.00343054101410344,0.0941958871622514,0.107643607937537,1.92929159499968e-187
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23496.Total Lipids in Large VLDL,28797,0.098362767711372,0.00342569074230677,0.0916484138564508,0.105077121566293,8.6723700559517e-179
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23497.Phospholipids in Large VLDL,28797,0.101555384520612,0.00344278077311982,0.0948075342052973,0.108303234835927,1.95078095894028e-188
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23498.Cholesterol in Large VLDL,28797,0.0925460991550863,0.00336409666296674,0.0859524696956715,0.0991397286145011,1.79676590043131e-164
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,28797,0.0832021406121446,0.00330950337903191,0.0767155139892421,0.0896887672350472,5.56424005275868e-138
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,28797,0.099944180272366,0.00342654019128427,0.0932281614974489,0.106660199047283,2.4088451935355e-184
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23501.Triglycerides in Large VLDL,28797,0.0963070849031818,0.00344193466220649,0.0895608929652571,0.103053276841107,5.30736915963119e-170
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,28797,0.0685430031996484,0.00324571140424379,0.0621814088473305,0.0749045975519662,3.02620784470313e-98
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23503.Total Lipids in Medium VLDL,28797,0.0773745927700126,0.00326779863391945,0.0709697074475305,0.0837794780924948,9.10919183342303e-123
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23504.Phospholipids in Medium VLDL,28797,0.0666032759633128,0.00323918043329617,0.0602544823140523,0.0729520696125733,2.83058923534833e-93
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23505.Cholesterol in Medium VLDL,28797,0.0351471022017233,0.00324605034263083,0.0287848435301669,0.0415093608732798,2.87373353650845e-27
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,28797,0.0167980366806242,0.00328416273674163,0.0103610777166106,0.0232349956446378,3.15984023521127e-07
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,28797,0.0566300185968446,0.00323219812487449,0.0502949102720905,0.0629651269215986,2.26105744675124e-68
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23508.Triglycerides in Medium VLDL,28797,0.0950453944168138,0.00338040964783087,0.0884197915070653,0.101670997326562,1.2882161234896e-171
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23509.Concentration of Small VLDL Particles,28797,0.0855436615639813,0.00330697584563488,0.0790619889065369,0.0920253342214257,7.17731336477298e-146
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23510.Total Lipids in Small VLDL,28797,0.0855080336653323,0.00329402961328594,0.0790517356232918,0.0919643317073727,7.16765109473846e-147
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23511.Phospholipids in Small VLDL,28797,0.0691985183824364,0.00324750614242191,0.0628334063432894,0.0755636304215833,5.64892799786913e-100
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23512.Cholesterol in Small VLDL,28797,0.062457167011661,0.00324216966989305,0.0561025144586706,0.0688118195646514,3.54925253587315e-82
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,28797,0.0671029010564338,0.00325396025163484,0.0607251389632295,0.0734806631496381,8.32769149254628e-94
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,28797,0.0533141685355377,0.00323218594181692,0.0469790840895765,0.0596492529814988,7.61492691539939e-61
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23515.Triglycerides in Small VLDL,28797,0.098306467761107,0.003390384760555,0.0916613136304192,0.104951621891795,3.1234740457709e-182
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,28797,0.0616425043578156,0.00327471182002498,0.0552240691905666,0.0680609395250646,1.43053585928014e-78
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,28797,0.0635125473908608,0.00328498927551882,0.0570739684108439,0.0699511263708777,9.28927083575434e-83
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,28797,0.0655297582807348,0.00327983998693076,0.0591012719063505,0.0719582446551191,3.2915146924795e-88
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,28797,0.0391720478437128,0.00333798212008802,0.0326296028883403,0.0457144927990854,9.93201486620228e-32
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,28797,0.0319940870804527,0.00336631251234088,0.0253961145562646,0.0385920596046408,2.1671489473662e-21
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,28797,0.0543612053007188,0.00328981367682014,0.0479131704941513,0.0608092401072862,4.70550338865659e-61
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,28797,0.094873910447277,0.00333989235457839,0.0883277214323034,0.101420099462251,4.41985718358767e-175
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23523.Concentration of IDL Particles,28797,0.0321868661597254,0.00327699512708291,0.0257639557106429,0.0386097766088079,9.82318883374326e-23
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23524.Total Lipids in IDL,28797,0.0276019369781575,0.00336131207804927,0.0210137653051809,0.0341901086511341,2.27197585961879e-16
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23525.Phospholipids in IDL,28797,0.0282006008408011,0.00336539268008474,0.021604431187835,0.0347967704937672,5.5501007561447e-17
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23526.Cholesterol in IDL,28797,0.0173911509851753,0.00337766460827831,0.0107709283529499,0.0240113736174008,2.63785799990218e-07
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23527.Cholesteryl Esters in IDL,28797,0.018447018401189,0.00337632774636822,0.0118294160183073,0.0250646207840707,4.70347861263019e-08
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23528.Free Cholesterol in IDL,28797,0.0137949489303141,0.00337595279101048,0.00717808145993352,0.0204118164006946,4.39610195239885e-05
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23529.Triglycerides in IDL,28797,0.0901777381615071,0.00331135908571666,0.0836874743535024,0.0966680019695118,2.94489954294196e-161
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23530.Concentration of Large LDL Particles,28797,0.0372029032345705,0.00323974156316938,0.0308530097707585,0.0435527966983825,1.8649951560251e-30
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23531.Total Lipids in Large LDL,28797,0.0328131211011682,0.00326715546313095,0.0264094963934315,0.0392167458089048,1.07545538920946e-23
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23532.Phospholipids in Large LDL,28797,0.0300482214845663,0.00326336886093547,0.0236520185171328,0.0364444244519998,3.55026692909332e-20
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23533.Cholesterol in Large LDL,28797,0.0271195408062302,0.00327722258589204,0.0206961845378818,0.0335428970745786,1.33765360717274e-16
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,28797,0.0321437538668002,0.00326448005047093,0.0257453729678771,0.0385421347657232,7.71131355929474e-23
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23535.Free Cholesterol in Large LDL,28797,0.0125532443592071,0.00331798436413427,0.00604999500550396,0.0190564937129103,0.000155016960651635
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23536.Triglycerides in Large LDL,28797,0.0918769080942639,0.00330728904828598,0.0853946215596234,0.0983591946289044,1.23139602071534e-167
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23537.Concentration of Medium LDL Particles,28797,0.051931249152624,0.00322852990538196,0.0456033305380753,0.0582591677671726,5.80968010902199e-58
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23538.Total Lipids in Medium LDL,28797,0.0511414350589132,0.00322753759660387,0.0448154613695696,0.0574674087482568,2.62068658645492e-56
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23539.Phospholipids in Medium LDL,28797,0.0468646392591301,0.00322724942149888,0.0405392303929923,0.0531900481252679,1.30446659799663e-47
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23540.Cholesterol in Medium LDL,28797,0.0471109928687874,0.00322702168829781,0.0407860303597237,0.0534359553778512,4.2415492081158e-48
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,28797,0.0559091983049994,0.00323114506075259,0.0495761539859243,0.0622422426240744,9.68888529635319e-67
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,28797,0.0208414098933586,0.00324386137603252,0.0144834415963349,0.0271993781903823,1.34037234704903e-10
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23543.Triglycerides in Medium LDL,28797,0.0984601917939476,0.00333352375086694,0.0919264852422484,0.104993898345647,6.50275281847153e-189
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23544.Concentration of Small LDL Particles,28797,0.0533371425275019,0.0032279139836992,0.0470104311194515,0.0596638539355524,4.73495917739477e-61
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23545.Total Lipids in Small LDL,28797,0.0466628257281554,0.00322776768564723,0.0403364010642868,0.0529892503920239,3.33041007531901e-47
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23546.Phospholipids in Small LDL,28797,0.0327724493648109,0.00323318782575358,0.0264354012263339,0.0391094975032879,4.18678308943931e-24
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23547.Cholesterol in Small LDL,28797,0.0430014957830579,0.00322701637520938,0.0366765436876475,0.0493264478784683,2.16879705044295e-40
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,28797,0.0550177319366653,0.00322711761413872,0.0486925814129534,0.0613428824603773,7.46192320854542e-65
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23549.Free Cholesterol in Small LDL,28797,0.00821201901916174,0.00324862709908488,0.00184470990495537,0.0145793281333681,0.0114818725995886
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23550.Triglycerides in Small LDL,28797,0.104504736020552,0.00336519833388133,0.0979089472861444,0.111100524754959,2.72076725203314e-208
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,28797,-0.0377096103583145,0.00381164346308308,-0.0451804315459574,-0.0302387891706717,4.84610750930962e-23
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23552.Total Lipids in Very Large HDL,28797,-0.0515684165491835,0.0038234011179212,-0.0590622827403091,-0.044074550358058,2.47195973774909e-41
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23553.Phospholipids in Very Large HDL,28797,-0.0521029022674962,0.00381311341957119,-0.0595766045698557,-0.0446291999651366,2.25491904185189e-42
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23554.Cholesterol in Very Large HDL,28797,-0.0614229011510868,0.00382569060122868,-0.068921254729495,-0.0539245475726786,9.34537103149524e-58
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,28797,-0.0650938362427776,0.0038657544284394,-0.0726707149225188,-0.0575169575630364,2.55879364610086e-63
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,28797,-0.0460640509996403,0.00363865022012862,-0.0531958054310924,-0.0389322965681883,1.2390345611872e-36
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23557.Triglycerides in Very Large HDL,28797,0.0750499618770253,0.00327657066585411,0.0686278833719513,0.0814720403820994,4.43280056147502e-115
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23558.Concentration of Large HDL Particles,28797,-0.0565076782834183,0.00393221151522698,-0.0642148128532632,-0.0488005437135734,1.15068402096066e-46
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23559.Total Lipids in Large HDL,28797,-0.0546757077066685,0.00390474383316835,-0.0623290056196785,-0.0470224097936586,2.10883703443899e-44
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23560.Phospholipids in Large HDL,28797,-0.0470564277266671,0.00386179044040099,-0.0546255369898531,-0.0394873184634812,4.52638502751654e-34
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23561.Cholesterol in Large HDL,28797,-0.0712895584357323,0.00392348338246197,-0.0789795858653577,-0.0635995310061068,2.29687917131136e-73
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,28797,-0.0761875434991099,0.00392069020016132,-0.0838720962914261,-0.0685029907067937,1.41727329211165e-83
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23563.Free Cholesterol in Large HDL,28797,-0.0534701303331305,0.00390967384142824,-0.0611330910623299,-0.0458071696039312,1.90814757952944e-42
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23564.Triglycerides in Large HDL,28797,0.0603646440776403,0.00336272323963011,0.0537737065279652,0.0669555816273153,1.15776732107885e-71
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23565.Concentration of Medium HDL Particles,28797,-0.0025024217655035,0.00356984191699918,-0.00949931192282189,0.0044944683918149,0.483315223430095
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23566.Total Lipids in Medium HDL,28797,0.00586191184334005,0.00352514226011421,-0.00104736698648379,0.0127711906731639,0.0963460240579251
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23567.Phospholipids in Medium HDL,28797,0.0163213340475153,0.00348398589812835,0.00949272168718372,0.0231499464078469,2.81687923273101e-06
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23568.Cholesterol in Medium HDL,28797,-0.0205057531369249,0.00359324153587832,-0.0275485065472464,-0.0134629997266034,1.16279372020439e-08
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,28797,-0.0243115291899489,0.00358066866708019,-0.0313296397774261,-0.0172934186024717,1.14579217907069e-11
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,28797,-0.00431217611770968,0.0036259719776853,-0.0114190811939729,0.00279472895855351,0.234352314442007
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23571.Triglycerides in Medium HDL,28797,0.0929386255551295,0.00330386492404267,0.0864630503040058,0.0994142008062531,8.83941052293371e-172
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23572.Concentration of Small HDL Particles,28797,0.0368088240220392,0.00324192748861221,0.0304546461443593,0.0431630018997191,8.20000491526249e-30
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23573.Total Lipids in Small HDL,28797,0.0540439161133973,0.00325650994240182,0.0476611566262898,0.0604266756005049,1.44874413173943e-61
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23574.Phospholipids in Small HDL,28797,0.055631399121083,0.00327086480320598,0.0492205041067993,0.0620422941353667,1.47806259395106e-64
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23575.Cholesterol in Small HDL,28797,0.0271207862868062,0.0032462562084949,0.0207581241181562,0.0334834484554562,6.86393771941877e-17
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,28797,0.0185011973389341,0.00323998751945545,0.0121508218008014,0.0248515728770668,1.1390772866605e-08
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23577.Free Cholesterol in Small HDL,28797,0.0492951761918734,0.00329145809871349,0.042843918318395,0.0557464340653519,1.61673540697373e-50
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23578.Triglycerides in Small HDL,28797,0.110299058437103,0.00345064365965211,0.103535796864184,0.117062320010021,2.41034122758106e-220
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27562,0.0234105167690384,0.003343246950028,0.0168577527469835,0.0299632807910933,2.57514265800289e-12
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27562,-0.0278063304922668,0.00338673379582878,-0.0344443287320912,-0.0211683322524423,2.30059060358946e-16
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27562,-0.0157068640140298,0.00335590347329897,-0.0222844348216958,-0.00912929320636383,2.87721638920708e-06
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27562,-0.0413484522729656,0.00342048366894125,-0.0480526002640905,-0.0346443042818408,1.477856031631e-33
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,27562,0.0142739204288977,0.00334004819945187,0.00772742595797206,0.0208204148998234,1.93015942816547e-05
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,28491,0.0258400252946105,0.00326035384134265,0.0194497317655789,0.0322303188236421,2.35431602999775e-15
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,28491,-0.0720693585029501,0.00353234683646531,-0.0789927583024221,-0.0651459587034781,7.19241193938989e-92
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,28491,-0.0740278007644301,0.00352519743862939,-0.0809371877441437,-0.0671184137847165,3.60996421495796e-97
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,28491,-0.0466038696046337,0.00344612833503225,-0.0533582811412969,-0.0398494580679705,1.52625911080339e-41
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,28491,0.0527766284183537,0.00345398609719313,0.0460068156678552,0.0595464411688523,1.68188996103333e-52
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,28792,0.0787111965018893,0.00342028266299643,0.0720074424824163,0.0854149505213623,3.8639103295818e-116
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,28792,-0.0271377300529788,0.00333868864273147,-0.0336815597927325,-0.0205939003132251,4.52815914543503e-16
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,28792,-0.0462024672827668,0.00345503121714865,-0.0529743284683782,-0.0394306060971555,1.15779670817265e-40
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,28792,0.0209044328795052,0.00327322496538771,0.0144889119473453,0.0273199538116652,1.72320826939311e-10
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,28792,-0.0108274244621667,0.00324196464256593,-0.0171816751615959,-0.00447317376273743,0.00083953535918823
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,28797,-0.026388593920376,0.00341361574825083,-0.0330792807869477,-0.0196979070538044,1.1070124082128e-14
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,28797,-0.0649957222856054,0.00354952116269837,-0.0719527837644942,-0.0580386608067166,1.78809446952026e-74
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,28797,-0.0710033722517938,0.00357175574549747,-0.0780040135129688,-0.0640027309906188,2.38236874208359e-87
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,28797,-0.0461042288501485,0.00347537468640051,-0.0529159632354935,-0.0392924944648035,4.78139103097365e-40
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,28797,0.0570190307344548,0.00352444375302774,0.0501111209785204,0.0639269404903891,1.30491023721121e-58
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,28797,-0.0562651983251751,0.0034594755868097,-0.0630457704753221,-0.049484626175028,3.26232262107417e-59
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,28797,-0.0405066980401864,0.00336520038592942,-0.047102490796608,-0.0339109052837647,2.73211440261391e-33
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,28797,-0.0242641289127657,0.00329044386415817,-0.0307133988865157,-0.0178148589390156,1.69891094348801e-13
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,28797,-0.0588295016801654,0.00347984409248805,-0.065649996101442,-0.0520090072588889,8.29354872225186e-64
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,28797,0.0459043857889496,0.00339563773274463,0.0392489358327701,0.0525598357451291,1.62582343938047e-41
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,28797,0.0276074162877179,0.00339556274621492,0.0209521133051367,0.0342627192702992,4.44765096973869e-16
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,28797,-0.0616126906614434,0.00353579225462857,-0.0685428434805154,-0.0546825378423714,1.17813341399985e-67
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,28797,-0.0627919112986104,0.00357070126777359,-0.0697904857834467,-0.0557933368137742,7.32058356053441e-69
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,28797,-0.0374944115022727,0.00328427767622545,-0.0439315957476746,-0.0310572272568708,4.02365055126202e-30
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,28797,0.0622437512482283,0.00351214540030251,0.0553599462636354,0.0691275562328212,6.62586839075599e-70
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,28797,-0.00349539540012828,0.00324257716476679,-0.00985084664307118,0.00286005584281462,0.281056936172371
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,28797,-0.0471677174333743,0.00340262597919458,-0.0538368643525957,-0.0404985705141529,1.48299174449596e-43
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,28797,-0.0346419694957958,0.00338103107989226,-0.0412687904123846,-0.0280151485792069,1.35978886927963e-24
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,28797,-0.0476949847299613,0.00330454719257124,-0.054171897227401,-0.0412180722325217,4.67585250966063e-47
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,28797,0.0629253243365564,0.00346641211241343,0.0561311565962261,0.0697194920768867,3.1250865066988e-73
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,28797,-0.0266745265206743,0.00325987609641562,-0.0330638836696489,-0.0202851693716996,2.88935552333791e-16
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,28797,-0.0502809609488965,0.00345606083539902,-0.0570548401862786,-0.0435070817115144,8.80790913830816e-48
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,28797,0.0113544937662518,0.00324333972691855,0.00499754790149148,0.0177114396310122,0.000464452848511934
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,28797,-0.0825418111816749,0.00354935800082033,-0.0894985528632828,-0.0755850695000671,1.55566197451692e-118
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,28797,0.0597519928601867,0.00341224861735857,0.0530639855701639,0.0664400001502095,2.66987433418094e-68
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,28797,-0.0498683755873937,0.00325454681429004,-0.0562472873434021,-0.0434894638313852,8.72052654110366e-53
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,28797,-0.0192957581827372,0.00329737968933325,-0.0257586223738304,-0.0128328939916441,4.91408154491931e-09
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,28797,0.0671584196228478,0.00330785280711943,0.0606750281208937,0.0736418111248019,5.28536779382339e-91
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,28797,-0.0989351239036476,0.00350653369326403,-0.105807929942445,-0.0920623178648501,8.75393397969399e-173
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,28797,0.0515230452212405,0.00334631292024491,0.0449642718975605,0.0580818185449206,2.79898839312808e-53
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,28797,-0.0731305989508184,0.00325757271731538,-0.0795154414767565,-0.0667457564248802,1.15786625744209e-110
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,28797,-0.000570822765888854,0.00327230489281249,-0.00698454035580134,0.00584289482402364,0.861520451235205
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,28797,0.0746876546887227,0.00325185452812218,0.0683140198136032,0.0810612895638421,1.07742812658923e-115
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,28797,-0.0870928843899008,0.00339348866854723,-0.0937441221802534,-0.0804416465995482,1.19941002272066e-143
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,28797,0.0803038547201392,0.00341209239172993,0.0736161536323485,0.0869915558079298,2.50287232632266e-121
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,28783,-0.0467222956799512,0.00366540831331518,-0.053906495974049,-0.0395380953858535,4.09260045785266e-37
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,28783,-0.0165088306574091,0.0034300508156105,-0.0232317302560056,-0.0097859310588125,1.49435877043135e-06
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,28783,-0.0450140240118425,0.00327813463826205,-0.0514391679028361,-0.0385888801208489,8.96140277262475e-43
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,28783,0.0431087855665356,0.0038601088249577,0.0355429722696185,0.0506745988634527,6.72436204318827e-29
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,28783,0.102880525644826,0.00357438360132486,0.0958747337862288,0.109886317503422,1.24522026245568e-179
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,28797,0.0676412822413875,0.00358304880146945,0.0606185065905073,0.0746640578922676,5.1857741164367e-79
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,28797,-0.099616664941007,0.00364985582660451,-0.106770382361152,-0.0924629475208622,5.89132260132014e-162
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,28797,-0.103101589511341,0.00358657996052268,-0.110131286233966,-0.0960718927887166,3.42485344639536e-179
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,28797,-0.0235190659923665,0.00356425812358729,-0.0305050119145976,-0.0165331200701354,4.22296732645914e-11
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,28797,0.0963512391097765,0.00351578032812455,0.0894603096666524,0.103242168552901,2.96015639308609e-163
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,28797,0.083652409050058,0.00360887541798298,0.0765790132308114,0.0907258048693046,8.77866636926555e-118
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,28797,-0.097911592199513,0.00353946463465585,-0.104848942883438,-0.0909742415155875,2.93548134107875e-166
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,28797,-0.0987690590653536,0.00343890535675523,-0.105509313564594,-0.0920288045661134,6.97166641889379e-179
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,28797,-0.0340208957425376,0.00379787670200447,-0.0414647340784664,-0.0265770574066088,3.50490535461741e-19
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,28797,0.0988053594039594,0.00345838274432586,0.0920269292250808,0.105583789582838,4.73311230465548e-177
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,28797,0.0160856363565111,0.00334632625839016,0.00952683689006639,0.0226444358229558,1.5401999194325e-06
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,28797,-0.0715528840777103,0.0033196017052847,-0.0780593034200683,-0.0650464647353522,3.0845534743769e-102
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,28797,-0.0682523549940255,0.00330174791992515,-0.0747237809170788,-0.0617809290709722,3.02459172195678e-94
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,28797,-0.0089822388697873,0.00348842603155298,-0.0158195538916311,-0.00214492384794346,0.0100327631841704
NFKBIE,NF-kappa-B inhibitor epsilon,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,28797,0.100399760686406,0.00352009799983318,0.0935003686067328,0.107299152766079,1.79453187956752e-176
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,49555,-0.0016834800533999,0.00280030671882289,-0.00717208122229277,0.00380512111549297,0.547724837938532
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,49555,-0.00323182854902063,0.0027308118204019,-0.00858421971700835,0.00212056261896709,0.236629379108826
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,46216,0.00348749651014497,0.00262888598808934,-0.00166512002651012,0.00864011304680007,0.184645533249359
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,46216,-0.00499591798430109,0.00286235115733495,-0.0106061262526776,0.000614290284075406,0.0809237197576233
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,46216,-0.00172217498286302,0.00282317329516825,-0.00725559464139278,0.00381124467566675,0.541855592792898
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,46216,0.00114814887271273,0.002590427927882,-0.00392908986593599,0.00622538761136146,0.657603271078403
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24009.Traffic intensity on the nearest road,49555,-0.0836114390224283,0.0345154194065942,-0.151261661059353,-0.0159612169855037,0.0154203490543755
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24010.Inverse distance to the nearest road,49555,-0.00125614575739234,0.00244516299009481,-0.00604866521797818,0.00353637370319349,0.607445303417134
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24011.Traffic intensity on the nearest major road,49555,0.00748883368435705,0.00244797558076327,0.00269080154606105,0.0122868658226531,0.00222051425133168
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24012.Inverse distance to the nearest major road,49555,-0.00436782479255593,0.00248572301404958,-0.00923984190009311,0.000504192314981257,0.0788959125402277
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24013.Total traffic load on major roads,49555,-0.0465704098691758,0.0238726328591953,-0.0933607702731986,0.000219950534846962,0.051088078649779
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24015.Sum of road length of major roads within 100m,49555,-0.045022074911658,0.0231770457974623,-0.0904490846746842,0.000404934851368152,0.0520787969963646
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,49555,-0.000717244590487712,0.00279831050698135,-0.00620193318417116,0.00476744400319574,0.79770988495041
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,49555,-0.00294518353557062,0.00279459250738859,-0.00842258485005225,0.00253221777891102,0.291939988298162
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,49555,0.000984414329821825,0.00276488942930508,-0.00443476895161612,0.00640359761125977,0.721811286808662
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,49456,0.0135738562266849,0.00271383761056346,0.0082547345099805,0.0188929779433893,5.70152780474603e-07
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24020.Average daytime sound level of noise pollution,49555,-0.00336555387392203,0.00245833688744124,-0.00818389417330686,0.00145278642546279,0.170993952260262
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24021.Average evening sound level of noise pollution,49555,-0.00331544476987672,0.002458140240567,-0.00813339964138803,0.0015025101016346,0.177419769077845
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24022.Average night-time sound level of noise pollution,49555,-0.00337145682667594,0.00245836094395824,-0.00818984427683408,0.0014469306234822,0.170248825254362
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24023.Average 16-hour sound level of noise pollution,49555,-0.00333745225453382,0.00245821405232797,-0.00815555179709665,0.00148064728802901,0.174573470026086
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24024.Average 24-hour sound level of noise pollution,49555,-0.00331921776307071,0.00245823343056391,-0.00813735528697597,0.00149891976083454,0.176943528798188
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X2405.Number of children fathered,22813,-0.0335635155842149,0.0258015021706399,-0.0841344598386691,0.0170074286702392,0.193327840560415
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",44217,-0.00152017291754951,0.00290131409661888,-0.00720674854692251,0.00416640271182349,0.600308896482308
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",44217,0.00102027129733465,0.0026294243060641,-0.00413340034255099,0.0061739429372203,0.698002516702753
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,"X24502.Water percentage, buffer 1000m",44217,-0.00439789793690831,0.00261475143125776,-0.00952281074217352,0.000727014868356889,0.0925843558528937
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,"X24503.Greenspace percentage, buffer 300m",44217,-0.000590907910306909,0.00272828490832091,-0.00593834633061589,0.00475653051000207,0.828532112301087
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",44217,-0.000668228970100518,0.00264992858108207,-0.00586208898902137,0.00452563104882033,0.800911864606441
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,"X24505.Water percentage, buffer 300m",44217,-0.00310640627002113,0.00262954504464528,-0.00826031455752589,0.00204750201748362,0.237471089972238
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",49792,-0.00631409025454512,0.00275277609505767,-0.0117095314008582,-0.000918649108232083,0.0218108860223078
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,"X24507.Natural environment percentage, buffer 300m",49792,-0.00520988686337366,0.00258697243887436,-0.0102803528435674,-0.000139420883179922,0.0440260908119223
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X24508.Distance (Euclidean) to coast,49792,0.00768660142650719,0.00246247851319061,0.00286014354065359,0.0125130593123608,0.00180041461094829
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,10954,-0.0111938751484574,0.0350595817445093,-0.0799106553676956,0.0575229050707808,0.749519171253123
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X2704.Years since last cervical smear test,20568,0.00788661568898463,0.0250671875206777,-0.0412450718515436,0.0570183032295129,0.753054077618608
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X2714.Age when periods started (menarche),26242,0.0368645626432238,0.0214191047751634,-0.00511688271609651,0.0788460080025442,0.0852432744628473
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X2734.Number of live births,27063,-0.0435350227942915,0.0205336087021505,-0.0837808958505065,-0.00328914973807642,0.0339996353276435
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X2744.Birth weight of first child,21469,-0.0610282700401352,0.0228700216733361,-0.105853512519874,-0.0162030275603964,0.00762518790086328
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X2754.Age at first live birth,18262,-0.011363301733294,0.0042409118902307,-0.0196754890381461,-0.00305111442844178,0.00738098613980194
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X2764.Age at last live birth,18214,-0.00682353770901796,0.004096083473388,-0.0148518613168584,0.00120478589882253,0.0957567553284242
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X2794.Age started oral contraceptive pill,20743,-0.00403923154399001,0.00461394457226504,-0.0130825629056295,0.00500409981764947,0.381344697357097
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X2804.Age when last used oral contraceptive pill,18828,-0.00532620752941892,0.00399080382708418,-0.0131481830305039,0.00249576797166607,0.182016822985907
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X2867.Age started smoking in former smokers,12251,0.00552388864820344,0.00500583813667111,-0.00428755409967194,0.0153353313960788,0.269836450034933
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",19101,-0.0287987992068418,0.0304212485600854,-0.0884244463846092,0.0308268479709256,0.343820357777561
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,19094,-0.00234124693944218,0.0335406502638232,-0.0680809214565356,0.0633984275776512,0.944350979055569
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,19131,0.0459902805746298,0.0342853118351369,-0.0212089306222384,0.113189491771498,0.179806901578838
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",19077,0.00608191415655915,0.0336340361318582,-0.0598407966618828,0.0720046249750011,0.856505938360887
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X28739.Difficulty with standing for long periods,19151,0.0484712586066758,0.0292281530419874,-0.00881592135561945,0.105758438568971,0.0972580504487622
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X28740.Difficulty with taking care of household responsibilities,19195,0.0690280877994733,0.032438408102595,0.00544880791838709,0.13260736768056,0.0333519584764415
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X28741.Difficulty learning a new task,19040,0.0441609488992355,0.036807412142316,-0.0279815788997039,0.116303476698175,0.230238132029254
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X28742.Difficulty with joining in community activities,18348,0.00770469476011988,0.0370248513275234,-0.064864013841826,0.0802734033620657,0.835156927463155
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X28743.Difficulty with being emotionally affected by health problems,19066,0.0531035997934584,0.0314006402842363,-0.00844165516364483,0.114648854750562,0.0908220411715095
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,19193,-0.0179241713286448,0.0451217263023824,-0.106362754881314,0.0705144122240247,0.691194635032872
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,11630,0.030600856631907,0.0337077698786002,-0.0354663723301494,0.0966680855939633,0.363987947691482
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X2897.Age stopped smoking,12259,0.0175643625150888,0.00521674844903397,0.00733953555498219,0.0277891894751953,0.000762473332352913
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,17131,-0.0161374546267993,0.00876605637444438,-0.0333189251207103,0.00104401586711166,0.0656531519898984
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,17131,0.0194285152191754,0.009553745556063,0.000703173929291881,0.0381538565090588,0.0420071411244513
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,17131,0.00746531150352153,0.0320097315930197,-0.0552737624187971,0.0702043854258402,0.815593318859392
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,17131,0.00405837924733207,0.0327404493490701,-0.0601129014768453,0.0682296599715094,0.901351469339621
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,17131,0.0246497487108682,0.036606250039507,-0.0470985013665656,0.0963979987883019,0.500717578626636
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,17131,0.0422915099823715,0.0309337087656581,-0.0183385591983183,0.102921579163061,0.171591282508232
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,17131,0.00513807961504405,0.0137859766519972,-0.0218824346228704,0.0321585938529585,0.709373861093492
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,17131,-0.012559418930673,0.0250383002180061,-0.061634487357965,0.036515649496619,0.615949538870793
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29002.Recent lack of interest or pleasure in doing things,17019,0.00177363645751209,0.0351977905538275,-0.0672140330279897,0.0707613059430139,0.95981174893481
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29003.Recent feelings of depression,17007,-0.0167704226872574,0.034153992819105,-0.0837122486127032,0.0501714032381884,0.623415969745512
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",17031,0.0266230629437448,0.0273840955776883,-0.0270497643885242,0.0802958902760139,0.330960426806337
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29005.Recent feelings of tiredness or low energy,17037,0.0219273728574363,0.0276030009855717,-0.0321745090742843,0.0760292547891568,0.426983190998556
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29006.Recent poor appetite or overeating,17050,0.0138353057723538,0.0384374370684074,-0.0615020708817248,0.0891726824264324,0.718893845525104
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29007.Recent feelings of inadequacy,16981,-0.0115167055871145,0.037163352511119,-0.0843568765089077,0.0613234653346787,0.756645256914652
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29008.Recent trouble concentrating on things,17045,0.0344847577010554,0.0364153377346614,-0.036889304258881,0.105858819660992,0.343660152268194
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29009.Recent changes in speed or amount of moving or speaking,17030,0.00460075716485804,0.0641358079387522,-0.121105426395096,0.130306940724812,0.942813955524431
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29010.Recent thoughts of suicide or self-harm,16946,0.00542879105256628,0.0715211782228747,-0.134752718264268,0.145610300369401,0.939495842543746
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29038#0.Substances taken for depression_None of options listed,15725,0.00153211148688866,0.0170352530465073,-0.0318569844842657,0.034921207458043,0.928337868301733
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),15725,-0.0430516511733439,0.032775314475569,-0.107291267545459,0.0211879651987713,0.189020596496719
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),15725,-0.0159862110111838,0.016871349275897,-0.0490540555919419,0.0170816335695743,0.343380288129595
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),15725,-0.0533673470362703,0.0493674637778253,-0.150127576040808,0.0433928819682673,0.279703626762424
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),15725,-0.0520399759823798,0.0314820141422,-0.113744723701092,0.00966477173633223,0.0983495081785413
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),15725,-0.0108319400674319,0.0339208289205823,-0.0773167647517732,0.0556528846169093,0.749480491954302
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),15725,-0.0455348105904994,0.0375827474057897,-0.119196995505847,0.0281273743248484,0.225688303283555
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),15725,0.0276491345873854,0.0449915866429468,-0.0605343752327903,0.115832644407561,0.538867376014084
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),15725,-0.0332295386782065,0.0332259728831411,-0.098352445529163,0.03189336817275,0.317273977056512
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,15725,-0.0157725451307177,0.0167184564958838,-0.0485407198626499,0.0169956296012144,0.345480046069321
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,15725,0.0161186631425098,0.025691217333727,-0.0342361228315952,0.0664734491166148,0.530406354173095
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,15725,0.0244900012706433,0.040614268970353,-0.0551139659112486,0.104093968452535,0.546523992791401
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,15725,0.0452847515974764,0.0521965023650801,-0.0570203930380806,0.147589896233033,0.385636395018369
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,15725,0.00851464450606969,0.0325747644012305,-0.055331893720342,0.0723611827324814,0.793796926002037
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,15725,0.111718511338241,0.0529138784880892,0.00800730950158632,0.215429713174896,0.0347599471461677
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,15725,-0.0234850242710133,0.0519705581247953,-0.125347318195612,0.0783772696535855,0.651353791161675
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,15725,-0.0440279817012398,0.0280701155768272,-0.0990454082318211,0.0109894448293416,0.116784583702422
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,15725,0.0225947253628732,0.0271744404433489,-0.0306671779060907,0.0758566286318371,0.405720943276772
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,15725,-0.0139126448367455,0.0387711363747851,-0.0899040721313243,0.0620787824578334,0.71971941102843
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29058.Recent feelings or nervousness or anxiety,16771,0.0171847694569968,0.0321717823755076,-0.0458719239989981,0.0802414629129916,0.593240289260607
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29059.Recent inability to stop or control worrying,16791,0.0087111222939508,0.0334283269379133,-0.0568083985043593,0.0742306430922609,0.794411103007926
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29060.Recent worrying too much about different things,16781,0.000561052799193012,0.0307728053088252,-0.0597536456061044,0.0608757512044905,0.985453913424443
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29061.Recent trouble relaxing,16784,0.0360627813789324,0.0324308298105328,-0.0275016450497119,0.0996272078075767,0.266158088444168
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29062.Recent restlessness,16802,0.0324539104627448,0.0461672551478639,-0.0580339096270684,0.122941730552558,0.482088040045653
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29063.Recent easy annoyance or irritability,16759,-0.00758001512814802,0.0330085979815854,-0.0722768671720553,0.0571168369157593,0.818376194259996
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29064.Recent feelings of foreboding,16747,0.00121842132649532,0.0377964987786019,-0.0728627162795644,0.075299558932555,0.974283949210824
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,15725,-0.0308769421193978,0.0178118401589827,-0.0657881488310039,0.00403426459220828,0.0830252877522419
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,15725,-0.0616522855695589,0.0296849016685332,-0.119834692839884,-0.00346987829923373,0.0378278930646877
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',15725,-0.0384474692192729,0.0384186022361823,-0.11374792960219,0.0368529911636444,0.316962433053662
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,15725,-0.024539659795787,0.0408247083580489,-0.104556088177563,0.0554767685859888,0.547783236449463
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29065#2.Symptoms of panic attack_Sweating,15725,-0.0393952255209716,0.026886193097485,-0.0920921639920422,0.0133017129500991,0.142870389426549
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,15725,-0.0115130528749642,0.028974833702689,-0.0683037269322348,0.0452776211823063,0.691117254849655
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,15725,-0.0411182412596476,0.0289736503791026,-0.0979065960026888,0.0156701134833936,0.155872257551921
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,15725,-0.031102637639726,0.0269200991909303,-0.0838660320539493,0.0216607567744974,0.247957080432725
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,15725,-0.0675229022685842,0.0353338237012131,-0.136777196722962,0.00173139218579346,0.0560228866670818
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29076.Felt loved as a child,16720,-0.0225934016617916,0.0283810185780084,-0.078220198074688,0.0330333947511049,0.426000120190844
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29077.Physically abused by family as a child,16750,-0.041392501670473,0.0385811715320873,-0.117011597873364,0.0342265945324182,0.283345848594118
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29078.Felt hated by family member as a child,16721,0.0621372702648592,0.0385942803399604,-0.0135075192014633,0.137782059731182,0.107414043005224
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29079.Sexually molested as a child,16595,0.024120208731265,0.0521295963053358,-0.0780538000271932,0.126294217489723,0.643587629427086
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29080.Someone to take to doctor when needed as a child,16688,-0.0315020362159387,0.0415739405809289,-0.112986959754559,0.049982887322682,0.448620260541742
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,16726,-0.0142863770926008,0.0541546653694055,-0.120429521216636,0.0918567670314341,0.791931931882081
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29082.Belittlement by partner or ex-partner as an adult,16621,0.042396513944249,0.042202677539364,-0.0403207340329044,0.125113761921402,0.31510751275993
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29083.Physical violence by partner or ex-partner as an adult,16739,0.00623821631087234,0.0475462534216574,-0.0869524403955762,0.0994288730173209,0.895616214092981
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,16690,0.0775971778754437,0.0668374304694328,-0.0534041858446447,0.208598541595532,0.245665083650902
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,16688,0.0314575972742827,0.0643065527836619,-0.0945832461816945,0.15749844073026,0.624719406000193
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29086.Experienced a violent or sexual assault,16742,-0.0542958321134506,0.0543279161667839,-0.160778547800347,0.0521868835734459,0.317610847249121
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29087.Experienced a life-threatening injury or illness,16739,-0.0334179089962851,0.0336505826979265,-0.099373051084221,0.0325372330916507,0.320682610392296
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29088.Experienced a marital separation or divorce,16747,-0.0388660352232045,0.0314194378108646,-0.100448133332499,0.02271606288609,0.21610219087459
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29089.Experienced the death of a spouse or partner,16767,0.000304665660691122,0.042512101409428,-0.0830190531017878,0.08362838442317,0.994282044166287
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,16745,-0.00133553021831215,0.0391384057895791,-0.0780468055658871,0.0753757451292628,0.972779263055511
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X29091.Frequency of drinking alcohol,16748,-0.114711717210176,0.0258108097462908,-0.165300904312906,-0.0641225301074456,8.87332787102156e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,14943,-0.114094291948435,0.0299053725783524,-0.172708822202006,-0.055479761694864,0.000136633883822322
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,14980,-0.100645040160212,0.0301664383368212,-0.159771259300381,-0.0415188210200425,0.000851005454168118
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29104.Ever used cannabis,16738,-0.0537697542831366,0.0373013864592054,-0.126880471743179,0.019340963176906,0.149463674870118
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29108.Ever thought that life not worth living,16659,0.0051448880850747,0.0326734798616536,-0.0588951324437665,0.0691849086139159,0.874881298827203
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29109.Ever contemplated self-harm,16698,-0.0135153479411105,0.0443297598831733,-0.10040167731213,0.0733709814299093,0.760459792764345
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29111.Ever self-harmed,16724,0.0718828260761628,0.0708167335401527,-0.0669179716625366,0.210683623814862,0.31009466759354
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,16720,-0.0980842156122879,0.0477299567329267,-0.191634930808824,-0.00453350041575162,0.0398962313645701
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,16998,-0.0547636375748559,0.0376890322291395,-0.128634140743969,0.0191068655942575,0.146231372636355
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,16998,-0.0477071511692462,0.0291129821311337,-0.104768596146268,0.0093542938077758,0.101296371180518
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,16998,-0.0292463700161799,0.0312243794801909,-0.0904461537973541,0.0319534137649943,0.348951035671239
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,16998,-0.0708594296215523,0.0420909816210164,-0.153357753598744,0.0116388943556398,0.0923001082556377
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,16705,-0.117050701360955,0.0295051442722295,-0.174880784134525,-0.0592206185873853,7.30476689922835e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X29153.Pain or discomfort today,16731,0.0383152060687519,0.027418799931404,-0.0154256417967999,0.0920560539343036,0.16230994894605
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29154.Anxiety or depression today,16731,0.0113954828601182,0.0344777492555948,-0.0561809056808476,0.078971871401084,0.741013479011283
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29166.Frequency of confiding in someone close,16314,-0.0213667152754695,0.026846680537237,-0.073986209128454,0.0312527785775149,0.426113830948822
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,16678,0.00920401364639451,0.00889724954593318,-0.00823459546363452,0.0266426227564236,0.300927519973496
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,16678,-0.0134457135006984,0.00892789416931046,-0.0309443860725469,0.00405295907115008,0.132077361864293
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,16678,-0.00545506574728502,0.0111057708173483,-0.0272223765492876,0.0163122450547176,0.623297127459271
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,16678,0.0116599038399597,0.0120377233021131,-0.0119340338321821,0.0352538415121014,0.332752017565358
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,16678,-0.033088732529681,0.0194225635501199,-0.0711569570879161,0.00497949202855414,0.0884701238048446
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,16678,-0.00378804508731435,0.0091936408704555,-0.0218075811934071,0.0142314910187784,0.680323592221954
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,16674,-0.00506150130483401,0.0100213520234824,-0.0247033512708595,0.0145803486611915,0.613515158209655
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,16674,-0.0205786582470195,0.0146518089064107,-0.0492962037035845,0.00813888720954551,0.16018474218184
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,16674,0.0167443644868178,0.0226060370428321,-0.0275634681171331,0.0610521970907687,0.458883843998632
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,16674,0.0470417126236058,0.0202748863002928,0.00730293547503198,0.0867804897721796,0.0203422884964064
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,16674,-0.0352147581843623,0.0299803984999302,-0.0939763392442256,0.023546822875501,0.240174480832568
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,16674,0.0228744106960163,0.0143862564635719,-0.00532265197258458,0.0510714733646173,0.111849660043393
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29171.Frequency of feeling 'in tune' with people,16394,0.0256393575817539,0.033586700024135,-0.0401905744655506,0.0914692896290584,0.445248819433855
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29172.Freuency of feeling that lacks companionship,16612,0.00928873044567674,0.0305144151235475,-0.0505195231964764,0.0690969840878299,0.760823427348791
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29173.Frequency of feeling left out,16525,0.00729287850624245,0.0316613933238383,-0.0547634524084807,0.0693492094209656,0.817830602111808
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29174.Frequency of feeling isolated from others,16588,0.0251820376330175,0.0326659789069901,-0.0388432810246831,0.0892073562907181,0.440780200266191
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29175.Tendency to bounce back quickly after hard times,16709,-0.00979432296048691,0.0270680008243876,-0.0628476045762866,0.0432589586553128,0.717475142699126
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29176.Ability to make it through stressful events,16709,-0.00630516851964354,0.0263442789467312,-0.0579399552552367,0.0453296182159497,0.810846985196909
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29177.Quick recovery from stressful events,16709,-0.0043130460303314,0.0268307556110877,-0.0569013270280632,0.0482752349674004,0.872292191839357
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29178.Hard to snap back when something bad happens,16709,0.00395136523970278,0.0264336736767857,-0.0478586351667973,0.0557613656462028,0.881174913742584
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29179.Comes through difficult times with little trouble,16709,0.0180428238735931,0.0268997861051092,-0.0346807568924209,0.0707664046396071,0.502394003615555
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29180.Tendency to take a long time to get over setbacks,16709,-0.0182844165311387,0.026561191737935,-0.0703443523374913,0.0337755192752139,0.491217787505459
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29181.General happiness,16615,0.0500886934882655,0.0276301096965777,-0.00406632151702684,0.104243708493558,0.0698760939824716
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,X29182.Belief that own life is meaningful,16423,-0.0353400354430133,0.027464812138247,-0.0891710672339774,0.0184909963479507,0.198203550437664
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,11146,0.0453547361606982,0.0325017293101786,-0.0183486532872519,0.109058125608648,0.162906183926855
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X2946.Father's age,10982,0.00491672833365231,0.00794735586793067,-0.0106600891674918,0.0204935458347964,0.536151791970382
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X2966.Age high blood pressure diagnosed,12573,-0.00330112584608461,0.00599128597780119,-0.0150440463625749,0.00844179467040573,0.581651797122299
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30000.White blood cell (leukocyte) count,48656,0.103507319663183,0.00256023361965837,0.0984892617686526,0.108525377557713,0
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,48657,0.0371565273181243,0.00290082426087859,0.0314709117668023,0.0428421428694464,1.67994497231653e-37
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30020.Haemoglobin concentration,48657,0.0181980916418666,0.00310992881818108,0.0121026311582316,0.0242935521255015,4.89947535491974e-09
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30030.Haematocrit percentage,48657,0.0269493595492594,0.00303621011585161,0.0209983877221902,0.0329003313763285,7.16182896511185e-19
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30040.Mean corpuscular volume,48657,-0.020768170311458,0.00256556157260798,-0.0257966709937696,-0.0157396696291463,5.85896542924464e-16
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30050.Mean corpuscular haemoglobin,48656,-0.0287139224993529,0.00257243885803636,-0.0337559026611042,-0.0236719423376016,6.77348944721771e-29
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,48656,-0.0212399096901712,0.00251228387531835,-0.0261639860857952,-0.0163158332945473,2.88136611496665e-17
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,48657,0.0140110611307052,0.00251124223403017,0.00908902635200608,0.0189330959094043,2.42721706886849e-08
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30080.Platelet count,48657,0.157384765215173,0.00247120243729286,0.152541208438079,0.162228321992267,0
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30090.Platelet crit,48657,0.145209928487119,0.002547188349686,0.140217439321735,0.150202417652504,0
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,48657,-0.0663839918144711,0.00244942527622316,-0.0711848653558685,-0.0615831182730737,1.46815979750453e-160
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30110.Platelet distribution width,48657,-0.0328628256528413,0.00249020964584915,-0.0377436365587057,-0.027982014746977,1.07119506987253e-39
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30120.Lymphocyte count,48584,0.0839222568269119,0.00253606608059337,0.0789515673089489,0.0888929463448749,1.7415034435528e-237
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30130.Monocyte count,48584,0.0639841470859071,0.00256457170125113,0.0589575865514549,0.0690107076203593,1.58181589525743e-136
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30140.Neutrophill count,48584,0.0719225572599019,0.00255228920042592,0.0669200704270671,0.0769250440927367,2.59809529925148e-173
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30150.Eosinophill count,48584,0.0459182631715967,0.00249756584747946,0.041023034110537,0.0508134922326564,3.10975691611245e-75
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30160.Basophill count,48584,0.275371084161237,0.0172292263684377,0.241601800479099,0.309140367843375,2.36016747494472e-57
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30170.Nucleated red blood cell count,48584,0.0725985138454938,0.0806349183548074,-0.0854459261299288,0.230642953820916,0.367945972094644
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30180.Lymphocyte percentage,48585,0.00852934021913708,0.00252105490769884,0.00358807260004735,0.0134706078382268,0.000716918887390059
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30190.Monocyte percentage,48585,-0.00941746777944578,0.0025535433374499,-0.0144224127208476,-0.00441252283804397,0.000226269902814395
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30200.Neutrophill percentage,48585,-0.00943365681631612,0.0024961065248493,-0.0143260256050208,-0.00454128802761149,0.000157426936987306
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30210.Eosinophill percentage,48585,0.0120776980305178,0.00247827006470046,0.00722028870370486,0.0169351073573307,1.10017378486061e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30220.Basophill percentage,48585,-0.00952842117054184,0.00246592863929992,-0.0143616413035697,-0.00469520103751399,0.000111676526192702
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30230.Nucleated red blood cell percentage,48583,0.075465753650616,0.0806640990633127,-0.0826358805134768,0.233567387814709,0.349506669546604
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30240.Reticulocyte percentage,47806,0.033804337214169,0.00265179456442724,0.0286068198678916,0.0390018545604464,3.69051556385182e-37
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30250.Reticulocyte count,47806,0.041038126758134,0.00270660216118604,0.0357331865222094,0.0463430669940587,8.30513901611618e-52
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30260.Mean reticulocyte volume,47806,-0.0168843833037851,0.00252823734160234,-0.0218397284933257,-0.0119290381142445,2.4433266966563e-11
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30270.Mean sphered cell volume,47806,-0.0133662364086784,0.00255059505751536,-0.0183654027214085,-0.0083670700959483,1.60874054906352e-07
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30280.Immature reticulocyte fraction,47806,0.0161546388028979,0.00265337246775053,0.0109540287661068,0.0213552488396889,1.1495261344221e-09
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30290.High light scatter reticulocyte percentage,47806,0.0327827554312588,0.00270743380104432,0.027476185181212,0.0380893256813057,1.0678920355084e-33
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30300.High light scatter reticulocyte count,47806,0.038592547675098,0.00274712264931086,0.0332081872824487,0.0439769080677473,9.68098518999835e-45
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30500.Microalbumin in urine,15751,0.0120656743992166,0.00441795295989641,0.00340648659781968,0.0207248622006136,0.00632021724654246
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,48759,0.00426206033075301,0.00268762110214025,-0.00100567702944189,0.00952979769094791,0.112788573007592
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30520.Potassium in urine,48659,-0.00565628101823713,0.00250121596588842,-0.0105586643113784,-0.000753897725095821,0.0237381223512419
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30530.Sodium in urine,48647,-0.000809733807484633,0.0026152715561621,-0.00593566605756234,0.00431619844259307,0.756853183032316
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30600.Albumin,43838,0.0243223963005866,0.0026937548223673,0.0190426368487467,0.0296021557524265,1.79805090123869e-19
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30610.Alkaline phosphatase,47830,0.0465810861738444,0.00257719466086319,0.0415297846385525,0.0516323877091362,8.87642297824904e-73
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30620.Alanine aminotransferase,47826,0.0341281099412156,0.00273494017013653,0.028767627207748,0.0394885926746831,1.11101657609061e-35
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30630.Apolipoprotein A,43569,-0.0180245050405639,0.00295361587682108,-0.0238135921591332,-0.0122354179219945,1.05286379518454e-09
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30640.Apolipoprotein B,47574,0.0504660189200061,0.00249199411321687,0.045581710458101,0.0553503273819112,8.37631618595315e-91
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30650.Aspartate aminotransferase,47683,0.0237403962780997,0.00259638411043025,0.0186514834216564,0.028829309134543,6.26926791567094e-20
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30660.Direct bilirubin,40608,-0.0337560710906752,0.00279104087496658,-0.0392265112056097,-0.0282856309757407,1.2912096536473e-33
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30670.Urea,47810,0.0024678655246397,0.0026412110443216,-0.00270890812223063,0.00764463917151002,0.350118341803253
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30680.Calcium,43836,0.0453066293576373,0.00260249045699987,0.0402057480619175,0.050407510653357,1.19292356278459e-67
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30690.Cholesterol,47841,0.0471823930055869,0.0025325876220879,0.0422185212662946,0.0521462647448792,3.43955855575773e-77
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30700.Creatinine,47822,-0.00306888240222135,0.00306672080482297,-0.00907965517967437,0.00294189037523167,0.31697458375471
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30710.C-reactive protein,47697,0.049699433912685,0.00279585387785426,0.0442195603120906,0.0551793075132793,1.82842337453174e-70
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30720.Cystatin C,47843,0.0469946012909962,0.0029248383541565,0.0412619181168495,0.052727284465143,6.12482548029114e-58
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30730.Gamma glutamyltransferase,47820,0.0534128367594438,0.00277774595342018,0.0479684546907403,0.0588572188281474,4.34070999252152e-82
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30740.Glucose,43784,0.00738612330627195,0.00268248539221666,0.0021284519375273,0.0126437946750166,0.00589928154876225
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),47576,0.0324249719763843,0.00270580632562834,0.0271215915781528,0.0377283523746159,4.84013702726325e-33
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30760.HDL cholesterol,43809,-0.0438673479078637,0.00307656994163824,-0.0498974249934747,-0.0378372708222527,5.03129305207888e-46
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30770.IGF-1,47590,-0.0113890381324377,0.00261940968684396,-0.0165230811186519,-0.00625499514622356,1.37706804648517e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30780.LDL direct,47734,0.0460803080370279,0.00249868945713736,0.0411828767010387,0.0509777393730171,1.11336042405446e-75
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30790.Lipoprotein A,38263,-0.00081166328276727,0.00278816124690518,-0.00627645932670143,0.00465313276116689,0.770968314651736
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30810.Phosphate,43737,0.0306775340346715,0.00270093691413393,0.025383697682969,0.035971370386374,7.44357586032922e-30
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30830.SHBG,43427,-0.0448307907247039,0.00310747965878064,-0.050921450855914,-0.0387401305934938,4.51568904069419e-47
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30840.Total bilirubin,47648,-0.0383906094737564,0.00265758957750234,-0.043599485045661,-0.0331817339018518,3.36098325165825e-47
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30850.Testosterone,43206,-0.00886931487551247,0.00434363768979643,-0.0173828447475135,-0.000355785003511458,0.0411665751325772
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30860.Total protein,43805,0.0525867586710219,0.00264331227651899,0.0474058666090447,0.0577676507329991,1.11478150773041e-87
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30870.Triglycerides,47806,0.113884763685612,0.0026769955116656,0.108637852482748,0.119131674888477,0
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30880.Urate,47778,0.0385415098283399,0.00313335521438109,0.0324001336081529,0.0446828860485268,1.01738592183089e-34
NFKBIE,NF-kappa-B inhibitor epsilon,Blood and urine assays,X30890.Vitamin D,45680,-0.0296861787647449,0.00281381281485237,-0.0352012518818555,-0.0241711056476342,5.43285377702808e-26
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X3137.Number of measurements made,45499,-0.00792486327686937,0.0196783036300487,-0.0464943383917649,0.0306446118380261,0.68715548225182
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X3143.Ankle spacing width,28468,-0.0121362342626959,0.00452359520053843,-0.0210024808557512,-0.00326998766964057,0.00730347465514072
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",28466,-0.00719409385546636,0.0034905758527618,-0.0140356225268795,-0.000352565184053233,0.0393116413968571
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X3146.Speed of sound through heel,28468,-0.0099309525135455,0.00337351519288733,-0.0165430422916047,-0.00331886273548633,0.00324471839940882
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",28468,-0.00927065532475852,0.00340864608836326,-0.0159516016579505,-0.00258970899156654,0.00653715078634747
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X3148.Heel bone mineral density (BMD),28447,-0.00920329649398263,0.00341393748372278,-0.0158946139620793,-0.00251197902588599,0.00702608907008339
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X3526.Mother's age at death,29913,-0.002551683,0.003299889,-0.009019465,0.003916099,0.4393727
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X3581.Age at menopause (last menstrual period),15493,-0.00629504147323045,0.00448038237741769,-0.0150765909329691,0.00248650798650822,0.160034426966307
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",9883,-0.00745572284928995,0.00576749913414228,-0.0187600211522088,0.00384857545362892,0.196140498459603
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X4100.Ankle spacing width (left),16122,0.00134061832466079,0.00589857011350692,-0.0102205790978128,0.0129018157471343,0.820210053846839
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X4101.Heel broadband ultrasound attenuation (left),16118,-0.0100172081147617,0.00454228418455294,-0.0189200851164854,-0.00111433111303791,0.0274454473393017
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X4103.Speed of sound through heel (left),16122,-0.0111036465409198,0.00438930141953638,-0.0197066773232111,-0.00250061575862851,0.0114252340038194
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",16122,-0.0111480114710889,0.00443525245081623,-0.0198411062746887,-0.00245491666748911,0.0119636197872023
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X4105.Heel bone mineral density (BMD) (left),16112,-0.0109430162736745,0.00443687781174484,-0.0196392967846944,-0.00224673576265459,0.0136590751421038
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",16122,-0.0111524609850392,0.00443525798683024,-0.0198455666392265,-0.00245935533085198,0.0119297559197535
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X4119.Ankle spacing width (right),16116,0.00493791840085545,0.00579545611708779,-0.00642117558863662,0.0162970123903475,0.394208588300221
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X4120.Heel broadband ultrasound attenuation (right),16115,-0.0105753456444911,0.00455268043850798,-0.0194985993039667,-0.00165209198501545,0.0201978159661839
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X4122.Speed of sound through heel (right),16116,-0.0103650971725757,0.00439050455686575,-0.0189704861040326,-0.00175970824111885,0.0182474774240977
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",16116,-0.010748096709884,0.00444078861927823,-0.0194520424036694,-0.00204415101609871,0.0155181616385358
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X4124.Heel bone mineral density (BMD) (right),16102,-0.0099121440807396,0.00444647456783038,-0.0186272342336871,-0.00119705392779206,0.0258134117687411
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",16116,-0.0107476505399002,0.00444079035278993,-0.0194515996313684,-0.00204370144843192,0.0155224889108987
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X4194.Pulse rate,16758,0.0358718224851526,0.00422456571462169,0.0275916736844941,0.0441519712858111,2.2135817009746e-17
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X4195.Pulse wave reflection index,16758,-0.0124266384536724,0.00434190244910264,-0.0209367672539136,-0.00391650965343121,0.00421463943757507
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X4196.Pulse wave peak to peak time,16747,-0.0127965289312658,0.00432315664613382,-0.0212699159576881,-0.00432314190484351,0.00308073691779377
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X4198.Position of the pulse wave peak,16758,0.0179712859149102,0.00435522834535676,0.00943503835801097,0.0265075334718095,3.70315367553869e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X4199.Position of pulse wave notch,16758,0.0244255524996658,0.00422133502433372,0.0161517358519717,0.0326993691473599,7.32756385411273e-09
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X4200.Position of the shoulder on the pulse waveform,16758,0.0196604234655751,0.00437983376508125,0.0110759492860159,0.0282448976451343,7.20858174369295e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X4269.Number of triplets attempted (left),16441,0.0071543967079506,0.0850900909644499,-0.159622181582371,0.173930974998272,0.932993647196092
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X4270.Volume level set by participant (left),16266,-0.0360815633457173,0.0268045893690697,-0.0886185585090939,0.0164554318176593,0.178290183182861
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X4276.Number of triplets attempted (right),16449,-0.0857445691762105,0.0813094389706619,-0.245111069558708,0.0736219312062868,0.291648382632
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X4277.Volume level set by participant (right),16256,0.015410820348781,0.0266510663500595,-0.0368252696973357,0.0676469103948977,0.563107386104081
NFKBIE,NF-kappa-B inhibitor epsilon,Cognitive function,X4288.Time to answer,16795,0.00684091035737225,0.00488610260811682,-0.00273585075453672,0.0164176714692812,0.161509332701447
NFKBIE,NF-kappa-B inhibitor epsilon,Cognitive function,X4290.Duration screen displayed,16795,-0.00133910587285924,0.0044671703590128,-0.0100947597765243,0.00741654803080584,0.764359349984428
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X46.Hand grip strength (left),50032,-0.0173452137501807,0.00352421017856179,-0.0242526657001618,-0.0104377618001996,8.60545416995253e-07
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X47.Hand grip strength (right),50038,-0.0163456040814076,0.00349555899873723,-0.0231968997189326,-0.00949430844388267,2.93135878100572e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X48.Waist circumference,50176,0.069022164595673,0.00544364555250461,0.058352619312764,0.0796917098785821,8.76075053717984e-37
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X4803.Tinnitus,16497,0.0077628568537475,0.0313192556377612,-0.0536228841962644,0.0691485979037594,0.804244183441653
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X4825.Noisy workplace,16700,0.0255370035920204,0.0351515346659694,-0.0433600043532795,0.0944340115373204,0.4675527214768
NFKBIE,NF-kappa-B inhibitor epsilon,Working and living environment,X4836.Loud music exposure frequency,16602,0.0427362768858103,0.0444600562533337,-0.0444054333707238,0.129877987142344,0.336451260140374
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X49.Hip circumference,50167,-0.0172635365510384,0.00436842603830739,-0.0258256515861209,-0.0087014215159559,7.76427169527131e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X50.Standing height,50124,-0.0228112891738986,0.00346676834319335,-0.0296061551265576,-0.0160164232212396,4.75112081501509e-11
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X5057.Number of older siblings,14725,0.0197450509560287,0.0285203657480244,-0.0361548659100991,0.0756449678221566,0.488751033852823
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,X51.Seated height,49898,-0.017516680550804,0.00322239262212047,-0.0238325700901601,-0.0112007910114479,5.47682423156823e-08
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X5181.Ever had eye surgery,11336,-0.00808645271308108,0.0659362179765221,-0.137321439947064,0.121148534520902,0.902393935564559
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X5186.Duration visual-acuity screen displayed (right),11307,0.00461880552458715,0.00508756767824983,-0.00535282712478251,0.0145904381739568,0.363970907985763
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X5188.Duration visual-acuity screen displayed (left),11305,0.00937645641703014,0.00513093671558208,-0.000680179545510732,0.019433092379571,0.0676606803932744
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X5190.Duration at which refractometer first shown (right),11178,0.00630291278007754,0.00516969656594074,-0.00382969248916632,0.0164355180493214,0.222792676284112
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X5193.Duration at which refractometer first shown (left),11175,0.00797804873752834,0.00519957535324168,-0.00221311895482536,0.018169216429882,0.124968119011697
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,"X5199.logMAR, initial (right)",11267,0.0295238770025682,0.0341424526094299,-0.0373953301119143,0.0964430841170508,0.387207460531625
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X5200.Final number of letters displayed (right),11267,-0.156089106657435,0.224487067518012,-0.596083758992738,0.283905545677867,0.486872607295318
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,"X5201.logMAR, final (right)",11158,0.00242308812333742,0.00518623723918034,-0.00774193686545605,0.0125881131121309,0.640355157441433
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X5202.Number of rounds to result (right),11267,0.0371377977189725,0.032084515677632,-0.0257478530091863,0.100023448447131,0.247093102503185
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,"X5206.logMAR, initial (left)",11260,0.0355372613333365,0.0338246277786479,-0.0307590091128133,0.101833531779486,0.29344987617566
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X5207.Final number of letters displayed (left),11260,-0.0516854875367332,0.201533222553331,-0.446690603741262,0.343319628667795,0.797599292911866
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,"X5208.logMAR, final (left)",11149,-0.000975156979512441,0.00518183275470089,-0.0111315491787262,0.00918123521970131,0.850732974987381
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X5209.Number of rounds to result (left),11254,0.0815726345533944,0.0320856441035932,0.0186847721103519,0.144460496996437,0.0110245958567006
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",10773,0.00867819923405016,0.00513595722467753,-0.00138827692631781,0.0187446753944181,0.0911153670478092
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",10773,0.0160263179779083,0.00511529676976652,0.00600033630916595,0.0260522996466507,0.00173483199429802
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X5256.Corneal hysteresis (right),10773,0.0100778318819029,0.00518155703834016,-7.80199132437796e-05,0.0202336836770497,0.0518078858017783
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X5257.Corneal resistance factor (right),10773,0.017171741600862,0.00515623639610798,0.00706551826449041,0.0272779649372337,0.000870486825467116
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",10749,0.0131279226300044,0.00515585853390889,0.00302243990354297,0.0232334053564658,0.0109036668581256
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",10749,0.0147331125760181,0.00511188243714509,0.00471382299921378,0.0247524021528225,0.00395779517126745
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X5264.Corneal hysteresis (left),10749,0.00173706525061807,0.00521135686149524,-0.0084771941979126,0.0119513246991487,0.738896968056475
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X5265.Corneal resistance factor (left),10749,0.00913369011859494,0.00516259010601642,-0.000984986489197247,0.0192523667263871,0.0768877380318592
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,11232,0.133966617132294,0.145755227361937,-0.151713628497103,0.419646862761691,0.358052312671652
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",50016,0.00404859583234815,0.0140526922987876,-0.0234946810732755,0.0315918727379718,0.773270559815872
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",50016,-0.024585165105403,0.0153581975230312,-0.0546872322505441,0.00551690203973812,0.10943096709051
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",50016,-0.00177720642452426,0.014646283022897,-0.0304839211494023,0.0269295083003538,0.903420796294218
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",50016,-0.0282152066010054,0.00626007007713319,-0.0404849439521865,-0.0159454692498244,6.58464680111994e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",50016,0.0225358390172611,0.00576144879725346,0.0112433993746443,0.0338282786598779,9.18502855675581e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",22588,-0.00801192739122647,0.00726850759627982,-0.0222582022799349,0.00623434749748198,0.27035190220015
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",22588,0.00839559400187196,0.0197778257572436,-0.0303689444823256,0.0471601324860695,0.671208680541548
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",22588,-0.00887036430940154,0.014116393574577,-0.0365384957155725,0.0187977670967694,0.529765804473125
NFKBIE,NF-kappa-B inhibitor epsilon,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",22588,0.0153066526260037,0.00860093694196264,-0.00155118378024306,0.0321644890322505,0.0751467989920372
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,50167,0.01946471894629,0.00963462257301377,0.000580858703183008,0.038348579189397,0.0433587571830099
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,50167,-0.00670306206823877,0.012449243902515,-0.0311035801171681,0.0176974559806906,0.590281740171507
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),50167,0.00758022899841966,0.00955778800030886,-0.0111530354821857,0.026313493479025,0.427726524737099
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',50167,-0.0175227573092643,0.0156841156350708,-0.048263623954003,0.0132181093354744,0.263901544846
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),50167,0.118434448004917,0.0378987737177473,0.0441528515181324,0.192716044491702,0.00177893995691596
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),50167,0.0623498191792364,0.0264008264662652,0.0106041993053566,0.114095439053116,0.0181970383630926
NFKBIE,NF-kappa-B inhibitor epsilon,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,50167,0.0814097795752882,0.0412181482576465,0.000622208990301007,0.162197350160275,0.0482627850251835
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,50015,-0.00301920058872716,0.00802160660373061,-0.0187415495320391,0.0127031483545848,0.706633387460793
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,50015,0.0238302662990153,0.0137152061741422,-0.00305153780230341,0.050712070400334,0.0823038823611977
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,50015,0.00846491332554502,0.00719323486201664,-0.0056338270040076,0.0225636536550976,0.23928568774008
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,50015,0.0291570454793727,0.0120174662367748,0.00560281165529399,0.0527112793034514,0.0152604308765392
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,50015,0.0294726705478748,0.0119543123045528,0.00604221843095119,0.0529031226647983,0.0136877437656021
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,50015,0.0225109945287042,0.00671145797399687,0.00935653689967037,0.0356654521577381,0.000796787075615956
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,15611,-0.0403968105318837,0.0158380875188707,-0.0714394620688703,-0.00935415899489708,0.0107628757004132
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,15611,-0.0266569222143422,0.0136135925239404,-0.0533395635612653,2.57191325809432e-05,0.0502348158616988
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,15611,0.00852348403636722,0.0188530153013057,-0.028428425954192,0.0454753940269264,0.651201862249525
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,15611,0.02742436327087,0.0150356495784417,-0.00204550990287566,0.0568942364446158,0.0681778500365999
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,49957,-0.000139370635744788,0.0203710844507098,-0.0400666961591361,0.0397879548876465,0.994541269778697
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6151#2.Fractured bone site(s)_Leg,49957,0.0170067908097279,0.0302408281668984,-0.042265232397393,0.0762788140168489,0.573860705874634
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6151#3.Fractured bone site(s)_Hip,49957,0.0114957300165972,0.0543306097202013,-0.0949922650349974,0.117983725068192,0.832428976811399
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6151#4.Fractured bone site(s)_Spine,49957,0.0342009611295479,0.0517848823257241,-0.0672974082288714,0.135699330487967,0.50897265524162
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,49957,0.0116365727424784,0.0176602814453723,-0.0229775788904514,0.0462507243754082,0.509955267347954
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6151#6.Fractured bone site(s)_Arm,49957,0.0430988152450494,0.0235252763622946,-0.0030107264250481,0.0892083569151469,0.0669541492226146
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,49957,0.0064813772022418,0.0108984445393012,-0.0148795740947886,0.0278423284992722,0.552042284776804
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",16168,0.0217770180493864,0.0175149569275438,-0.0125522975285994,0.0561063336273723,0.213761213530608
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",16168,-0.00226977765771982,0.0189008652884408,-0.0393154736230639,0.0347759183076242,0.904414489607759
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",16168,0.0180840247172643,0.0256055872468697,-0.0321029262866004,0.068270975721129,0.480040955310482
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",16168,0.0317742775074384,0.00899386686916665,0.0141462984438718,0.0494022565710051,0.000412201700103572
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",22744,-0.00311261760833782,0.00830817069674591,-0.0193966321739598,0.0131713969572842,0.707927728081885
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",22744,-0.00513378774521789,0.00811591173954972,-0.0210409747547353,0.0107733992642996,0.527028455378045
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",22744,0.0159921249434455,0.00741518331697674,0.00145836564217114,0.0305258842447199,0.0310416121527693
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",22745,0.0372006860446512,0.01755811859622,0.0027867735960599,0.0716145984932425,0.0341251988402798
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",22745,0.0188250203173913,0.0105194050228478,-0.0017930135273905,0.0394430541621731,0.073539298794059
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",22745,-0.0121240778707528,0.0141727134001892,-0.0399025961351236,0.015654440393618,0.392309911112096
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,50015,0.00065028765860566,0.016763084641995,-0.0322053582397046,0.0335059335569159,0.969055708351894
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,50015,0.0198564086958107,0.0117634045186172,-0.00319986416067903,0.0429126815523004,0.0914210249846356
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,50015,0.0160196431719385,0.0323830230596746,-0.0474510820250238,0.0794903683689007,0.620819271090828
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,50015,-0.00572162542118335,0.0120848268266244,-0.0294078860013672,0.0179646351590005,0.635890445060539
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,50015,0.0107268684996526,0.0138268192671138,-0.0163736972638903,0.0378274342631956,0.437869808860204
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),50015,0.00663510222555723,0.0158596795592623,-0.024449869710597,0.0377200741617114,0.675683572332274
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,50015,-0.0131556039780638,0.0052159175640858,-0.023378802403672,-0.0029324055524556,0.0116653099768034
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,9731,-3.70277960243308e-05,0.0152405026682101,-0.0299084130257162,0.0298343574336675,0.99806153916015
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,9731,0.0332351128806263,0.0189691250943258,-0.00394437230425234,0.0704145980655049,0.0797944203859625
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,9731,-0.0254680316980981,0.013480117685317,-0.0518890623613195,0.000952998965123217,0.0588809367922172
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,9731,-0.00209115405666912,0.0120273734119601,-0.025664805944111,0.0214824978307727,0.861974215734941
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,50244,0.0217458408508323,0.0061051107322227,0.00977982381567583,0.0337118578859888,0.000368510297909392
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,50244,0.0289761951366081,0.0175647043648677,-0.00545062541853258,0.0634030156917488,0.0990140307463289
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,50244,0.00178944878813672,0.00571112372272228,-0.00940435370839896,0.0129832512846724,0.754033603190469
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,50244,0.00150793172347471,0.00552466358194805,-0.00932040889714348,0.0123362723440929,0.784896279390553
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,50244,0.0229174794082427,0.00854837567881664,0.00616266307776213,0.0396722957387234,0.00734448549694537
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,50244,0.0067459521446087,0.00762767032692341,-0.00820428169616117,0.0216961859853786,0.37648169043537
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,50244,-0.0046140101200602,0.00593871037898254,-0.016253882462866,0.00702586222274558,0.437198973754327
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,50244,0.0681550695538166,0.0176349062672435,0.0335906532700193,0.102719485837614,0.000111328130056822
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,34767,-0.0227492500468546,0.00600602326533031,-0.034521055646902,-0.0109774444468071,0.000152280209785748
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,34767,-0.00200630232468423,0.00627024460960673,-0.0142959817595134,0.010283377110145,0.748991526253987
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,34767,0.0186293791785804,0.00706588848356465,0.00478023775079368,0.0324785206063671,0.00837976980349244
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,34768,-0.00175432676174922,0.00969982508184548,-0.0207659839221664,0.0172573303986679,0.856477194070439
NFKBIE,NF-kappa-B inhibitor epsilon,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,34768,0.00579392209926384,0.00633913759363865,-0.00663078758426792,0.0182186317827956,0.360727302924693
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,49781,-0.00872048890800135,0.0061641114587506,-0.0208021473671525,0.00336116955114983,0.157157000336416
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,49781,0.00512147439043161,0.00490404297482685,-0.004490449840229,0.0147333986210922,0.296334491336381
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,49781,0.00467564847163165,0.0054393383757993,-0.00598545474493497,0.0153367516881983,0.390014404549815
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,49781,-0.0186472097935199,0.00984108166112939,-0.0379357298493335,0.000641310262293741,0.0581202730724754
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),49816,-0.00823611770476929,0.00541720959986142,-0.0188538485204977,0.0023816131109591,0.1284264568008
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,49816,-0.0246561911251879,0.00844741837625339,-0.0412131311426446,-0.0080992511077313,0.00351556650780231
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),50015,0.00155564539862884,0.00532777331830228,-0.00888679030524362,0.0119980811025013,0.770297078844907
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,50015,-0.0090198064067663,0.00631247049642821,-0.0213922485797656,0.003352635766233,0.153042989747923
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,50015,0.00392478109967871,0.00951150532730273,-0.0147177693418346,0.0225673315411921,0.679875738710946
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,50015,0.00284466527881745,0.0120923835778985,-0.0208564065338636,0.0265457370914985,0.814020025354771
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,50015,0.0242739297777335,0.0131608076791696,-0.00152125327343886,0.0500691128289059,0.0651292728527813
NFKBIE,NF-kappa-B inhibitor epsilon,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,50015,-0.00230133271853797,0.015646140934088,-0.0329677689493505,0.0283651035122745,0.883064509454867
NFKBIE,NF-kappa-B inhibitor epsilon,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",28468,-0.00927209352525338,0.00340865191472497,-0.0159530512781143,-0.00259113577239245,0.00652890895196722
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X864.Number of days or week walked 10+ minutes,49154,-0.0566628974126295,0.0153196458947466,-0.0866894033663329,-0.0266363914589261,0.000216935619648322
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X874.Duration of walks,42580,-0.00640298341320946,0.00262359590885283,-0.011545231394561,-0.00126073543185792,0.014669484181721
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,47518,-0.0443346019100428,0.0148872131348329,-0.0735135396543152,-0.0151556641657703,0.00290251823112414
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X894.Duration of moderate activity,36779,-0.0337727511103421,0.0180436849012721,-0.0691383735168355,0.00159287129615127,0.0612530917712699
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X90087.No-wear time bias adjusted average acceleration,10475,-0.00163173161956533,0.00572548993876962,-0.0128536918995538,0.00959022866042312,0.775654201173211
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,47438,-0.0567468318558468,0.0152362032915546,-0.0866097903072938,-0.0268838734043998,0.000195950086353468
NFKBIE,NF-kappa-B inhibitor epsilon,Physical activities,X914.Duration of vigorous activity,26558,-0.00206537634678454,0.00332629814477368,-0.00858492071054095,0.00445416801697187,0.534655356900358
